###begin article-title 0
###xml 21 42 21 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum</italic>
###xml 21 42 <span type="species:ncbi:5833">Plasmodium falciparum</span>
The Motor Complex of Plasmodium falciparum
###end article-title 0
###begin p 1
###xml 129 156 129 156 <email xmlns:xlink="http://www.w3.org/1999/xlink">judith.green@nimr.mrc.ac.uk</email>
 MRC National Institute for Medical Research, The Ridgeway, London NW7 1AA, UK. Tel.: 44-2088162402; Fax: 44-2088162730; E-mail: judith.green@nimr.mrc.ac.uk. 
###end p 1
###begin p 2
###xml 36 60 36 60 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Medical Research Council</grant-sponsor>
Recipient of a studentship from the Medical Research Council.
###end p 2
###begin p 3
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Author's Choice</italic>
Author's Choice
###end p 3
###begin p 4
 applies to Author Choice Articles
###end p 4
###begin p 5
###xml 45 57 45 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apicomplexan</italic>
###xml 276 297 276 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum</italic>
###xml 605 618 605 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum</italic>
###xml 869 877 869 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 276 297 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 605 618 <span type="species:ncbi:5833">P. falciparum</span>
Calcium-dependent protein kinases (CDPKs) of Apicomplexan parasites are crucial for the survival of the parasite throughout its life cycle. CDPK1 is expressed in the asexual blood stages of the parasite, particularly late stage schizonts. We have identified two substrates of Plasmodium falciparum CDPK1: myosin A tail domain-interacting protein (MTIP) and glideosome-associated protein 45 (GAP45), both of which are components of the motor complex that generates the force required by the parasite to actively invade host cells. Indirect immunofluorescence shows that CDPK1 localizes to the periphery of P. falciparum merozoites and is therefore suitably located to act on MTIP and GAP45 at the inner membrane complex. A proportion of both GAP45 and MTIP is phosphorylated in schizonts, and we demonstrate that both proteins can be efficiently phosphorylated by CDPK1 in vitro. A primary phosphorylation of MTIP occurs at serine 47, whereas GAP45 is phosphorylated at two sites, one of which could also be detected in phosphopeptides purified from parasite lysates. Both CDPK1 activity and host cell invasion can be inhibited by the kinase inhibitor K252a, suggesting that CDPK1 is a suitable target for antimalarial drug development.
###end p 5
###begin p 6
###xml 49 78 49 78 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">National Institutes of Health</grant-sponsor>
###xml 85 100 85 100 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink">0600370P7601176</grant-num>
###xml 138 177 138 177 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">United Kingdom Medical Research Council</grant-sponsor>
###xml 182 196 182 196 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Wellcome Trust</grant-sponsor>
###xml 203 209 203 209 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink">066742</grant-num>
###xml 352 365 352 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">advertisement</italic>
This work was supported, in whole or in part, by National Institutes of Health Grant 0600370P7601176. This work was also supported by the United Kingdom Medical Research Council and Wellcome Trust Grant 066742. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
###end p 6
###begin p 7
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Author's Choice</italic>
Author's Choice-Final version full access.
###end p 7
###begin p 8
###xml 41 42 41 42 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn4">3</xref>
###xml 111 112 111 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref1">1</xref>
###xml 160 177 160 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Toxoplasma gondii</italic>
###xml 182 203 182 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum</italic>
###xml 490 492 490 492 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 730 731 730 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref2">2</xref>
###xml 160 177 <span type="species:ncbi:5811">Toxoplasma gondii</span>
###xml 182 203 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Calcium dependent protein kinases (CDPKs)3 are enzymes found in plants and organisms in the Alveolate lineage (1). These include Apicomplexan parasites such as Toxoplasma gondii and Plasmodium falciparum, the causative agent of the most severe form of malaria. CDPKs are characterized by their unique regulatory structure. They possess a catalytic kinase domain that is tethered to a calmodulin-like regulatory domain by a junction domain. Activation of the kinase occurs upon binding of Ca2+ to the calmodulin-like domain with associated binding of the junction domain by the N-lobe of the calmodulin-like domain. Inhibition of the kinase active site is relieved when this binding occurs, allowing phosphorylation of substrates (2).
###end p 8
###begin p 9
###xml 9 19 9 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium</italic>
###xml 79 80 79 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 214 232 214 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium berghei</italic>
###xml 651 652 643 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref4">4</xref>
###xml 654 655 646 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref5">5</xref>
###xml 702 712 694 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. berghei</italic>
###xml 971 972 963 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref6">6</xref>
###xml 214 232 <span type="species:ncbi:5821">Plasmodium berghei</span>
###xml 702 712 <span type="species:ncbi:5821">P. berghei</span>
CDPKs in Plasmodium are present as a multigene family comprising five members (3). Each gene is expressed predominantly at a distinct phase of the parasite life cycle. For example, CDPK3 is expressed in ookinetes. Plasmodium berghei parasites without a functional CDPK3 gene (DeltaCDPK3) have a reduced ability to invade the midgut of the mosquito host and also show a reduction in the gliding motility phenotype characteristic of this parasite stage. However, sporozoites from DeltaCDPK3 parasites are indistinguishable from wild-type parasites, with normal gliding motility, and the asexual blood stages develop and invade red blood cells normally (4, 5). PbCDPK4 is up-regulated in sexual stages of P. berghei and has been shown to be crucial in the development of parasites at a very specific stage of the life cycle; it regulates cell cycle progression in the male gameto-cyte and is therefore important in sexual reproduction and transmission to the mosquito host (6). These data suggest that different CDPKs are functional at different stages of the parasite life cycle.
###end p 9
###begin p 10
###xml 5 11 5 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 13 14 13 14 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref7">7</xref>
###xml 147 148 147 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 179 192 179 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum</italic>
###xml 308 309 308 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
###xml 421 422 421 422 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 443 444 443 444 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 641 642 641 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 677 687 677 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. berghei</italic>
###xml 798 799 798 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn5">4</xref>
###xml 901 911 901 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium</italic>
###xml 1005 1013 1005 1013 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1131 1133 1131 1133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref10">10</xref>
###xml 141 144 <span type="species:ncbi:11263?0.47540983606557374|species:ncbi:12167?0.09016393442622951">PVM</span>
###xml 179 192 <span type="species:ncbi:5833">P. falciparum</span>
###xml 677 687 <span type="species:ncbi:5821">P. berghei</span>
Zhao et al. (7) first identified PfCDPK1, and it has been proposed that the protein is associated with the parasitophorous vacuole membrane (PVM) (8). During the asexual cycle of P. falciparum, expression of CDPK1 is restricted to late blood stages of the parasite and is at its highest in mature schizonts (9). The protein is membrane-associated by virtue of dual acylation of its N terminus, with myristate added at Gly2 and palmitate at Cys3, followed by a stretch of amino acids enriched in basic residues. Mutagenesis studies have shown the importance of each of these three features in conferring membrane localization to the protein (8). Disruption of the cdpk1 gene in P. berghei has not been possible, suggesting that it is indispensable for parasite viability in the asexual blood stages.4 Although CDPK1 has been shown to phosphorylate the exogenous substrates casein and histone, only one Plasmodium protein, Raf kinase inhibitor protein (RKIP), has been shown to be phosphorylated by PfCDPK1 in vitro; it was proposed to be a regulator of PfCDPK1, perhaps by modulating the activity of the kinase to other substrates (10).
###end p 10
###begin p 11
###xml 211 221 211 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium</italic>
###xml 247 256 247 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T. gondii</italic>
###xml 258 259 258 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref4">4</xref>
###xml 261 262 261 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref5">5</xref>
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 733 743 733 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium</italic>
###xml 745 747 745 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 997 999 997 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref13">13</xref>
###xml 1134 1136 1134 1136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref14">14</xref>
###xml 1138 1140 1138 1140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref15">15</xref>
###xml 1432 1434 1432 1434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 247 256 <span type="species:ncbi:5811">T. gondii</span>
It is possible that the substrates of CDPKs are directly involved in motility and cell invasion; CDPK3 knock-out parasites or parasites treated with inhibitors of CDPKs show reduced gliding and invasion in both Plasmodium and the related parasite T. gondii (4, 5, 11). We have therefore reinvestigated the subcellular location of CDPK1 in asexual blood stages and examined phosphorylation by CDPK1 of components of the motor complex. Myosin A (MyoA), the myosin light chain known as myosin tail domain interacting protein (MTIP), and the 50- and 45-kDa glideosome-associated proteins (GAP50 and GAP45) are present in a heterotetrameric complex at the inner membrane complex (IMC), under the plasma membrane of the invasive stages of Plasmodium (12). GAP45 is a membrane-anchored protein of unknown function. Like CDPK1, it undergoes dual acylation of its N terminus, resulting in the addition of myristate and palmitate groups that, together, are capable of providing a stable membrane anchorage (13). MTIP binds strongly to the short tail of MyoA and shares homology with calmodulin and related proteins such as myosin light chains (14, 15). The force required for the parasite to invade its host cell is generated by translocation of actin filaments by MyoA. The actin filaments themselves are linked, indirectly, to adhesins that traverse the parasite plasma membrane and interact with receptors on the host erythrocyte surface (16). The net result of the myosin power stroke is forward propulsion of the parasite into the forming parasitophorous vacuole within the host cell.
###end p 11
###begin p 12
Here we reinvestigate the subcellular localization of CDPK1 and identify substrates. We demonstrate that CDPK1 is located at the periphery of merozoites and can phosphorylate both GAP45 and MTIP. We identify phosphorylated peptides of GAP45 and MTIP and show that both proteins are phosphorylated in the parasite. The potential role of these phosphorylation events in regulating the actin-myosin motor is discussed.
###end p 12
###begin title 13
EXPERIMENTAL PROCEDURES
###end title 13
###begin p 14
###xml 0 16 0 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Parasite Culture</italic>
###xml 17 30 17 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum</italic>
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref17">17</xref>
###xml 317 318 317 318 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 400 401 400 401 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 583 585 583 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref18">18</xref>
###xml 17 30 <span type="species:ncbi:5833">P. falciparum</span>
Parasite Culture-P. falciparum clone 3D7 was cultured, and merozoites were purified according to previously described methods (17). Invasion inhibition assays were carried out by the addition of K252a (Biomol) to late stage schizonts at a starting parasitaemia of 0.5%, with 2% hematocrit. The solvent used was 10% Me2SO, and inhibitor was added to the appropriate final concentration with a final Me2SO concentration of 0.5%. Invasion rates were measured using a FACSCalibur machine (Becton Dickinson) 48 h after the addition of inhibitor according to previously described methods (18). These data were confirmed by microscopic examination of Giemsa-stained smears of parasite cultures.
###end p 14
###begin p 15
###xml 241 242 235 236 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 245 246 239 240 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 248 249 242 243 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 344 345 338 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
Total parasite lysates were prepared by the addition of reducing SDS-PAGE sample buffer to cell pellets, followed by heating the sample to 95 degreesC for 5 min. Carbonate extracts of merozoites were prepared by incubating merozoites in 0.1 m Na2CO3, pH 11.0, on ice for 20 min. Supernatants were collected by ultra-centrifugation at 100,000 x g in a Beckman TL-100 ultracentrifuge. The carbonate-insoluble pellet was resuspended in reducing SDS-PAGE sample buffer. For immunoblots, carbonate-soluble and insoluble fractions were separated by SDS-PAGE on a 12% BisTris NuPAGE gel (Invitrogen), transferred to Protran membrane (Whatman), and incubated with the appropriate antibodies.
###end p 15
###begin p 16
###xml 0 35 0 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Recombinant Proteins and Antibodies</italic>
###xml 213 219 213 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 283 289 283 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 490 491 490 491 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 507 508 504 505 <sc xmlns:xlink="http://www.w3.org/1999/xlink">d</sc>
Recombinant Proteins and Antibodies-Open reading frames for PfCDPK1, PfMTIP, PfGAP50, and PfGAP45 were amplified from late schizont cDNA and cloned into the expression vectors pET30XaLIC, (PfCDPK1 and PfMTIP; for Fig. 3 only), pET46EkLIC (PfMTIP, in all experiments barring those in Fig. 3), pET30XaLIC (PfGAP50), and pQE60 (PfGAP45). PfCDPK1 was expressed in BL21(DE3) pLysS cells, PfMTIP, and PfGAP50 in BL21(DE3) cells and PfGAP45 in BL21 cells (all Stratagene). After induction with 1 mm isopropyl beta-d-thiogalactopyranoside, the cells were lysed in Bugbuster (Novagen) and His-tagged proteins purified on nickel-nitrilotriacetic acid-agarose (Qiagen) in the cases of CDPK1, GAP50, and MTIP and TALON resin (Clontech) in the case of GAP45. Recombinant MSP7-22 was a gift from Dr. Madhusudan Kadekoppala (National Institute for Medical Research).
###end p 16
###begin p 17
###xml 71 74 71 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink">191</sup>
###xml 393 395 393 395 <sup xmlns:xlink="http://www.w3.org/1999/xlink">47</sup>
###xml 400 402 400 402 <sup xmlns:xlink="http://www.w3.org/1999/xlink">51</sup>
###xml 407 409 407 409 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 414 416 414 416 <sup xmlns:xlink="http://www.w3.org/1999/xlink">58</sup>
###xml 425 427 425 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink">61</sup>
A kinase-dead mutant of CDPK1 was produced in which Asn substituted Asp191 of the catalytic triad. This was achieved using a QuikChange II mutagenesis kit (Stratagene) according to the manufacturer's instructions with the primers: 5'-CATAAACATAATATTGTACATCGAAATATTAAACCAG-3' and 5'-CTGGTTTAATATTTCGATGTACAATATTATGTTTATG-3'. Similarly, recombinant MTIP with single amino acid substitutions (Ser47, Ser51, Ser55, Ser58, and Ser61 substituted with alanine) or double S47A/S51A substitutions were generated using a QuikChange II mutagenesis kit (Stratagene).
###end p 17
###begin p 18
###xml 96 108 96 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GACGACGACAAG</italic>
###xml 148 163 148 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAGGAGAAGCCCGGT</italic>
###xml 576 578 576 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 617 619 617 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref20">20</xref>
###xml 640 642 640 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref21">21</xref>
###xml 420 424 <span type="species:ncbi:10090">mice</span>
###xml 447 454 <span type="species:ncbi:9986">rabbits</span>
###xml 556 562 <span type="species:ncbi:9986">rabbit</span>
###xml 581 586 <span type="species:ncbi:10090">mouse</span>
###xml 622 628 <span type="species:ncbi:9986">rabbit</span>
###xml 649 655 <span type="species:ncbi:9986">rabbit</span>
A fragment encoding the calmodulin-like domain of CDPK1 was also amplified using the primers 5'-GACGACGACAAGATGGCAACAATATTAATAAAAGTGATCAA-3' and 5'-GAGGAGAAGCCCGGTTTATGAAGATTTATTATCACAAATTTTGTG-3', where the bases in italics represent vector-specific sequence to generate overhangs for ligation-independent cloning into pET46EkLIC. Purified recombinant protein was used as an antigen. The antisera were raised in Balb/c mice and New Zealand White rabbits for each of the purified recombinant proteins, using standard procedures. Other antibodies used were rabbit anti-PTRAMP (19), mouse monoclonal 89.1 against MSP1 (20), rabbit anti-MSP7 (21), and rabbit anti-PfCRT (from the Malaria Reagent and Research Resource Centre (MR4)).
###end p 18
###begin p 19
###xml 0 18 0 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Immunofluorescence</italic>
###xml 264 270 <span type="species:ncbi:9913">bovine</span>
Immunofluorescence-Thin smears of parasites were air-dried and then fixed using 3% paraformaldehyde in phosphate-buffered saline (PBS) for 30 min at room temperature. The cells were permeabilized with 0.1% Triton X-100 in PBS for 10 min followed by blocking in 3% bovine serum albumin in PBS overnight at 4 degreesC. Antibodies were diluted in blocking buffer and incubated on the slide for 1 h followed by washing in PBS. Antigen visualization was achieved using Alexa-Fluor-488- or 594-conjugated anti-species antibodies (Molecular Probes). The images were processed using a DeltaVision cooled charge-coupled device imaging system (Applied Precision Inc.). Images from the fluorescence microscope were collected and analyzed with Softworx and prepared for publication with Adobe Photoshop.
###end p 19
###begin p 20
###xml 0 52 0 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cell Lysis and Shrimp Alkaline Phosphatase Treatment</italic>
###xml 198 199 186 187 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 208 209 196 197 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 234 235 222 223 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 300 301 287 288 <sup xmlns:xlink="http://www.w3.org/1999/xlink">8</sup>
###xml 807 808 784 785 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1085 1086 1050 1051 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1095 1096 1060 1061 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
Cell Lysis and Shrimp Alkaline Phosphatase Treatment-Synchronized schizonts (approximately40-45 h) were lysed in 0.15% saponin in Tris-buffered saline. Parasites were lysed in a buffer containing 7 m urea, 2 m thiourea, 4% CHAPS, 25 mm Tris (all PlusOne reagents; GE Healthcare), using 250 mul/1 x 108 cells. To ensure complete lysis, the cells were frozen in a dry ice/ethanol bath and thawed at 29 degreesC five times. Insoluble material was pelleted by centrifugation. An alkaline phosphatase reaction was set up using 300 mug of cell lysate, 3 mul of protease inhibitor mix (GE Healthcare), 20 units of shrimp alkaline phosphatase (SAP; Promega), in a total of 300 mul. A control reaction was set up in parallel as above but with the addition of 6 mul of phosphatase inhibitor mixture I (Sigma) and 20 mm imidazole. The lysates were incubated at 37 degreesC for 30 min and then heated to 65 degreesC for 15 min to inactivate the SAP. The proteins were precipitated using methanol/chloroform, followed by an acetone precipitation, and resuspended in rehydration buffer containing 6 m urea, 2 m thiourea, and 4% CHAPS.
###end p 20
###begin p 21
###xml 0 52 0 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Two-dimensional Electrophoresis and Western Blotting</italic>
###xml 620 621 618 619 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 642 643 640 641 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1466 1468 1463 1465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref22">22</xref>
###xml 1018 1024 <span type="species:ncbi:9986">rabbit</span>
###xml 1060 1066 <span type="species:ncbi:9986">rabbit</span>
###xml 1096 1107 <span type="species:ncbi:3704">horseradish</span>
###xml 1135 1141 <span type="species:ncbi:9986">rabbit</span>
Two-dimensional Electrophoresis and Western Blotting-Rehydration buffer containing 0.01% dithiothreitol, 0.002% bromphenol blue and 0.02% immobilized pH gradient buffer was added to 50 mug of control treated or SAP treated schizont lysate to give a total volume of 125 mul/sample. Isoelectric focusing was carried out on IPGPhor (GE Healthcare) using 7-cm immobilized pH gradient strips (pH 3-10NL; GE Healthcare) to a maximum voltage of 5000 V, collecting a total of 22000 Vh. After isoelectric focusing, immobilized pH gradient strips were incubated for 15 min at room temperature in equilibration buffer (2% SDS, 50 mm Tris-HCl, pH 8.8, 6 m urea, 30% (v/v) glycerol, 0.002% bromphenol blue) with 10 mg/ml dithiothreitol, followed by a second incubation in equilibration buffer containing 25 mg/ml iodoacetamide. The strips were run in parallel in the second dimension using NuPAGE 4-12% BisTris Zoom gels (Invitrogen). The gels were blotted onto polyvinylidene difluoride membrane and probed with affinity-purified rabbit anti-MTIP (4 mug/ml) or polyclonal rabbit anti-GAP45 (1/500), using an horseradish peroxidase-conjugated anti-rabbit IgG (1/15,000; Sigma) as a secondary antibody. The signal was detected using SuperSignal West Pico Chemiluminescent Substrate (Pierce). Samples from a parasite time course were lysed in the same buffer but separated by one-dimensional SDS-PAGE. Scanning densitometry of autoradiographs was performed using Image J software (22).
###end p 21
###begin p 22
###xml 0 26 0 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kinase Assays and Kinetics</italic>
###xml 158 159 158 159 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 182 183 182 183 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 188 189 188 189 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 197 198 196 197 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 222 224 217 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 234 235 229 230 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 240 241 235 236 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
Kinase Assays and Kinetics-Radiolabeled phosphate incorporation kinase assays were carried out with 15 pmol of CDPK1 and 200 pmol of substrate protein in 20 mm Tris-HCl, pH 8.0, 20 mm MgCl2, 100 mum ATP, 0.1 MBq of [gamma-32P]ATP, 1 mm CaCl2. The reactions were incubated for 15 min at 30 degreesC, stopped by the addition of reducing sample buffer, and analyzed by SDS-PAGE. After fixation in a solution of 30% methanol plus 5% glycerol, the gels were dried and exposed to BiomaxMR film (Kodak). To prepare samples for mass spectrometry and fluorimetric analysis, 3.5 nmol of substrate proteins were incubated with 150 pmol of CDPK1 under the same conditions (without radiolabeled ATP) for 16 h at room temperature.
###end p 22
###begin p 23
###xml 114 120 114 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 122 124 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref23">23</xref>
###xml 241 242 241 242 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 262 263 262 263 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 268 269 268 269 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 275 276 275 276 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 281 282 281 282 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 305 306 305 306 <sc xmlns:xlink="http://www.w3.org/1999/xlink">l</sc>
###xml 374 375 374 375 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 402 403 402 403 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 516 517 516 517 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 515 517 515 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 582 583 581 582 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 743 744 735 736 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 981 983 969 971 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 990 992 978 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref24">24</xref>
###xml 295 298 <span type="species:ncbi:9823">pig</span>
###xml 340 346 <span type="species:ncbi:9986">rabbit</span>
Kinase activity measurements were made using a continuous spectrophotometric assay based on one described by Cook et al. (23). A typical assay contained the following components in a total volume of 0.5 ml in a 10-mm-pathlength cuvette: 50 mm Hepes (pH 7.5), 1 mm CaCl2, 10 mm MgCl2, 6 units of pig heart l-lactic dehydrogenase, 4 units of rabbit muscle pyruvate kinase, 1 mm phosphoenolpyruvate, 250 mm NADH. Concentrations of ATP and MTIP (or GAP45) were varied as appropriate. In experiments for determining the Km for MTIP and GAP45, the concentration of ATP was fixed at 700 mum. The reactions were initiated by the addition of CDPK1 (at 10-15 mug/ml), and the rates (at 30 degreesC) were obtained by recording absorbance changes at 340 nm. Kinetic parameters were determined by direct nonlinear least squares fits to the Michaelis-Menten equation using CURFIT software (Dr. S. R. Martin). This coupled assay was validated by comparison with a radio-metric assay using [gamma-32P]ATP (24).
###end p 23
###begin p 24
###xml 0 34 0 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAP45 Purification from Merozoites</italic>
###xml 63 64 63 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 76 77 73 74 <sc xmlns:xlink="http://www.w3.org/1999/xlink">d</sc>
###xml 99 100 96 97 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 114 115 111 112 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 127 128 124 125 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 230 231 227 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 523 524 520 521 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 851 852 846 847 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 346 352 <span type="species:ncbi:9986">rabbit</span>
GAP45 Purification from Merozoites-Merozoites were lysed in 1% n-octyl-beta-d-glucopyranoside, 50 mm Tris-HCl, 5 mm EDTA, 150 mm NaCl, pH 8.0, on ice for 20 min. The supernatants were collected by ultracentrifugation at 100,000 x g in a Beckman TL-100 ultracentrifuge. GAP45 was purified from these supernatants using an immunoaffinity column of rabbit anti-GAP45 antibodies cross-linked to cyanogen bromide-activated Sepharose (GE Healthcare). After extensive washing with lysis buffer and PBS, GAP45 was eluted using 0.1 m glycine, pH 2.7, and separated by SDS-PAGE, and the relevant band was excised from the gel. The protein bands were reduced with dithiothreitol and alkylated using iodoacetamide. The gel was dried and reswollen in a sufficient volume to cover of 2 ng/mul modified sequencing grade trypsin or 1 ng/mul AspN (both Promega) in 5 mm ammonium bicarbonate. After overnight digestion at 32 degreesC, the supernatant was acidified by the addition of a 1/10th volume of 4% trifluoroacetic acid.
###end p 24
###begin p 25
###xml 0 31 0 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Purification of Phosphopeptides</italic>
Purification of Phosphopeptides-Recombinant proteins were phosphorylated by CDPK1, subjected to digestion with trypsin (MTIP) or AspN (GAP45) and phosphopeptides enriched by purification on either gallium spin columns (Pierce) for GAP45 or TALON magnetic beads (Clontech) for MTIP according to the manufacturer's instructions.
###end p 25
###begin p 26
###xml 0 58 0 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Peptide Mass Fingerprinting by MALDI-TOF Mass Spectrometry</italic>
###xml 587 588 587 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">m</italic>
###xml 589 590 589 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z</italic>
###xml 740 742 736 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref25">25</xref>
Peptide Mass Fingerprinting by MALDI-TOF Mass Spectrometry-Peptides from protease digestion were analyzed by MALDI-TOF, and the spectra were examined to identify phosphorylated peptides. Peptide mass fingerprinting was performed using a Reflex III MALDI time-of-flight mass spectrometer (Bruker Daltonik GmbH, Bremen, Germany), equipped with a nitrogen laser and a Scout-384 probe, to obtain positive ion mass spectra of digested protein with pulsed ion extraction in reflectron mode. An accelerating voltage of 26 kV was used with detector bias gating set to 2 kV and a mass cut-off of m/z 650. The matrix surfaces were prepared using recrystallized alpha-cyano-4-hydroxycinammic acid and nitrocellulose using the fast evaporation method (25). 0.4 mul of acidified digestion supernatant was deposited on the matrix surface and allowed to dry prior to desalting with water.
###end p 26
###begin title 27
RESULTS
###end title 27
###begin p 28
###xml 0 84 0 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Expression of PfCDPK1 in Merozoites and Localization to the Parasite Plasma Membrane</italic>
###xml 261 262 261 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 255 262 255 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 371 372 371 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 695 696 695 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 689 696 689 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 771 773 771 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 869 870 869 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 863 870 863 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 342 345 <span type="species:ncbi:11263?0.47540983606557374|species:ncbi:12167?0.09016393442622951">PVM</span>
###xml 420 423 <span type="species:ncbi:11263?0.47540983606557374|species:ncbi:12167?0.09016393442622951">PVM</span>
Expression of PfCDPK1 in Merozoites and Localization to the Parasite Plasma Membrane-We used anti-CDPK1 antibodies in a Western blot with schizont and merozoite cell lysates. It is evident that PfCDPK1 is present in free merozoites, as well as schizonts (Fig. 1A). In previously published work it was suggested that PfCDPK1 is located in the PVM of developing parasites (8), but because free merozoites do not contain a PVM, it is clear that CDPK1 must be present in another location in the parasite. The protein from merozoites is still associated with membranes, as demonstrated by partitioning of CDPK1 in the insoluble fraction of merozoites extracted with a high pH carbonate buffer (Fig. 1B). The same fraction contains membrane-associated proteins such as PTRAMP (19). By contrast, peripheral membrane proteins such as MSP7 are solubilized by this buffer (Fig. 1B).
###end p 28
###begin p 29
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 1.</label>
###xml 9 61 9 61 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CDPK1 is an integral membrane protein in merozoites.</bold>
###xml 61 62 61 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 122 123 122 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 142 143 142 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M</italic>
###xml 163 164 163 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 260 267 260 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lanes 1</italic>
###xml 293 300 293 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 2</italic>
###xml 337 344 337 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 3</italic>
###xml 387 394 387 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">numbers</italic>
###xml 402 406 402 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left</italic>
###xml 9 485 9 485 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="30"><bold>CDPK1 is an integral membrane protein in merozoites.</bold><italic>A</italic>, Western blot analysis using rabbit anti-CDPK1 antibodies. <italic>S</italic>, schizont lysate; <italic>M</italic>, merozoite lysate. <italic>B</italic>, Western blots of merozoites extracts using anti-CDPK1, anti-PTRAMP, and anti-MSP7 antibodies. <italic>Lanes 1</italic>, total merozoite lysate; <italic>lanes 2</italic>, carbonate buffer soluble fraction; <italic>lanes 3</italic>, carbonate buffer insoluble fraction. The <italic>numbers</italic> on the <italic>left</italic> of each panel indicate the positions of molecular mass markers in kilodaltons.</p>
###xml 9 485 9 485 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="30"><bold>CDPK1 is an integral membrane protein in merozoites.</bold><italic>A</italic>, Western blot analysis using rabbit anti-CDPK1 antibodies. <italic>S</italic>, schizont lysate; <italic>M</italic>, merozoite lysate. <italic>B</italic>, Western blots of merozoites extracts using anti-CDPK1, anti-PTRAMP, and anti-MSP7 antibodies. <italic>Lanes 1</italic>, total merozoite lysate; <italic>lanes 2</italic>, carbonate buffer soluble fraction; <italic>lanes 3</italic>, carbonate buffer insoluble fraction. The <italic>numbers</italic> on the <italic>left</italic> of each panel indicate the positions of molecular mass markers in kilodaltons.</p></caption>
###xml 485 485 485 485 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0470855330001"/>
###xml 0 485 0 485 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig1"><label>FIGURE 1.</label><caption><p textid="30"><bold>CDPK1 is an integral membrane protein in merozoites.</bold><italic>A</italic>, Western blot analysis using rabbit anti-CDPK1 antibodies. <italic>S</italic>, schizont lysate; <italic>M</italic>, merozoite lysate. <italic>B</italic>, Western blots of merozoites extracts using anti-CDPK1, anti-PTRAMP, and anti-MSP7 antibodies. <italic>Lanes 1</italic>, total merozoite lysate; <italic>lanes 2</italic>, carbonate buffer soluble fraction; <italic>lanes 3</italic>, carbonate buffer insoluble fraction. The <italic>numbers</italic> on the <italic>left</italic> of each panel indicate the positions of molecular mass markers in kilodaltons.</p></caption><graphic xlink:href="zbc0470855330001"/></fig>
###xml 92 98 <span type="species:ncbi:9986">rabbit</span>
FIGURE 1.CDPK1 is an integral membrane protein in merozoites.A, Western blot analysis using rabbit anti-CDPK1 antibodies. S, schizont lysate; M, merozoite lysate. B, Western blots of merozoites extracts using anti-CDPK1, anti-PTRAMP, and anti-MSP7 antibodies. Lanes 1, total merozoite lysate; lanes 2, carbonate buffer soluble fraction; lanes 3, carbonate buffer insoluble fraction. The numbers on the left of each panel indicate the positions of molecular mass markers in kilodaltons.
###end p 29
###begin p 30
###xml 0 52 0 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CDPK1 is an integral membrane protein in merozoites.</bold>
###xml 52 53 52 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 113 114 113 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 133 134 133 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M</italic>
###xml 154 155 154 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 251 258 251 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lanes 1</italic>
###xml 284 291 284 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 2</italic>
###xml 328 335 328 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 3</italic>
###xml 378 385 378 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">numbers</italic>
###xml 393 397 393 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left</italic>
###xml 83 89 <span type="species:ncbi:9986">rabbit</span>
CDPK1 is an integral membrane protein in merozoites.A, Western blot analysis using rabbit anti-CDPK1 antibodies. S, schizont lysate; M, merozoite lysate. B, Western blots of merozoites extracts using anti-CDPK1, anti-PTRAMP, and anti-MSP7 antibodies. Lanes 1, total merozoite lysate; lanes 2, carbonate buffer soluble fraction; lanes 3, carbonate buffer insoluble fraction. The numbers on the left of each panel indicate the positions of molecular mass markers in kilodaltons.
###end p 30
###begin p 31
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 2.</label>
###xml 9 62 9 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CDPK1 localizes to the plasma membrane of merozoites.</bold>
###xml 62 63 62 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 142 149 142 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel i</italic>
###xml 172 180 172 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel ii</italic>
###xml 187 199 187 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">second panel</italic>
###xml 276 280 276 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blue</italic>
###xml 360 361 360 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 363 370 363 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel i</italic>
###xml 494 503 494 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrowhead</italic>
###xml 542 550 542 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel ii</italic>
###xml 567 576 567 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel iii</italic>
###xml 718 727 718 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrowhead</italic>
###xml 810 818 810 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel iv</italic>
###xml 831 838 831 838 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel v</italic>
###xml 855 867 855 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink">third panels</italic>
###xml 1070 1074 1070 1074 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blue</italic>
###xml 1119 1120 1119 1120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1134 1137 1134 1137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 1149 1154 1149 1154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 1292 1304 1292 1304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">third panels</italic>
###xml 1359 1374 1359 1374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">white scale bar</italic>
###xml 9 1433 9 1432 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="32"><bold>CDPK1 localizes to the plasma membrane of merozoites.</bold><italic>A</italic>, an anti-CDPK1 antibody detects CDPK1 at the parasite periphery in schizonts (<italic>panel i</italic>) and free merozoites (<italic>panel ii</italic>). The <italic>second panel</italic> shows a merged image of nuclear staining with 4&#8242;,6&#8242;-diamino-2-phenylindole (<italic>blue</italic>) and the bright field image, and the third panel shows the bright field image. <italic>B</italic>, <italic>panel i</italic>, CDPK1 colocalizes with MTIP around the periphery of merozoites but is also found around the residual body, marked with an <italic>arrowhead</italic>, from which MTIP is absent. In young (<italic>panel ii</italic>) and segmented (<italic>panel iii</italic>) schizonts, CDPK1 colocalizes with the plasma membrane marker MSP1. Both proteins are also detected around the residual body, marked with an <italic>arrowhead</italic>. CDPK1 does not colocalize with the food vacuole marker PfCRT in either immature (<italic>panel iv</italic>) or mature (<italic>panel v</italic>) schizonts. The <italic>third panels</italic> in all of the images show the merged images of the antibody staining, beside which is a merged image of the bright field image and the nuclei of the parasites stained with 4&#8242;,6&#8242;-diamino-2-phenylindole (<italic>blue</italic>), followed by the bright field image alone. <italic>C</italic>, both CDPK1 (<italic>red</italic>) and MSP1 (<italic>green</italic>) can be detected on residual bodies that are released upon schizont rupture. The merged images of the antibody staining are shown in the <italic>third panels</italic>, followed by the bright field image. In all cases the <italic>white scale bar</italic> in the first panel of each set of images represents 1 &#956;m.</p>
###xml 9 1433 9 1432 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="32"><bold>CDPK1 localizes to the plasma membrane of merozoites.</bold><italic>A</italic>, an anti-CDPK1 antibody detects CDPK1 at the parasite periphery in schizonts (<italic>panel i</italic>) and free merozoites (<italic>panel ii</italic>). The <italic>second panel</italic> shows a merged image of nuclear staining with 4&#8242;,6&#8242;-diamino-2-phenylindole (<italic>blue</italic>) and the bright field image, and the third panel shows the bright field image. <italic>B</italic>, <italic>panel i</italic>, CDPK1 colocalizes with MTIP around the periphery of merozoites but is also found around the residual body, marked with an <italic>arrowhead</italic>, from which MTIP is absent. In young (<italic>panel ii</italic>) and segmented (<italic>panel iii</italic>) schizonts, CDPK1 colocalizes with the plasma membrane marker MSP1. Both proteins are also detected around the residual body, marked with an <italic>arrowhead</italic>. CDPK1 does not colocalize with the food vacuole marker PfCRT in either immature (<italic>panel iv</italic>) or mature (<italic>panel v</italic>) schizonts. The <italic>third panels</italic> in all of the images show the merged images of the antibody staining, beside which is a merged image of the bright field image and the nuclei of the parasites stained with 4&#8242;,6&#8242;-diamino-2-phenylindole (<italic>blue</italic>), followed by the bright field image alone. <italic>C</italic>, both CDPK1 (<italic>red</italic>) and MSP1 (<italic>green</italic>) can be detected on residual bodies that are released upon schizont rupture. The merged images of the antibody staining are shown in the <italic>third panels</italic>, followed by the bright field image. In all cases the <italic>white scale bar</italic> in the first panel of each set of images represents 1 &#956;m.</p></caption>
###xml 1433 1433 1432 1432 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0470855330002"/>
###xml 0 1433 0 1432 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig2"><label>FIGURE 2.</label><caption><p textid="32"><bold>CDPK1 localizes to the plasma membrane of merozoites.</bold><italic>A</italic>, an anti-CDPK1 antibody detects CDPK1 at the parasite periphery in schizonts (<italic>panel i</italic>) and free merozoites (<italic>panel ii</italic>). The <italic>second panel</italic> shows a merged image of nuclear staining with 4&#8242;,6&#8242;-diamino-2-phenylindole (<italic>blue</italic>) and the bright field image, and the third panel shows the bright field image. <italic>B</italic>, <italic>panel i</italic>, CDPK1 colocalizes with MTIP around the periphery of merozoites but is also found around the residual body, marked with an <italic>arrowhead</italic>, from which MTIP is absent. In young (<italic>panel ii</italic>) and segmented (<italic>panel iii</italic>) schizonts, CDPK1 colocalizes with the plasma membrane marker MSP1. Both proteins are also detected around the residual body, marked with an <italic>arrowhead</italic>. CDPK1 does not colocalize with the food vacuole marker PfCRT in either immature (<italic>panel iv</italic>) or mature (<italic>panel v</italic>) schizonts. The <italic>third panels</italic> in all of the images show the merged images of the antibody staining, beside which is a merged image of the bright field image and the nuclei of the parasites stained with 4&#8242;,6&#8242;-diamino-2-phenylindole (<italic>blue</italic>), followed by the bright field image alone. <italic>C</italic>, both CDPK1 (<italic>red</italic>) and MSP1 (<italic>green</italic>) can be detected on residual bodies that are released upon schizont rupture. The merged images of the antibody staining are shown in the <italic>third panels</italic>, followed by the bright field image. In all cases the <italic>white scale bar</italic> in the first panel of each set of images represents 1 &#956;m.</p></caption><graphic xlink:href="zbc0470855330002"/></fig>
FIGURE 2.CDPK1 localizes to the plasma membrane of merozoites.A, an anti-CDPK1 antibody detects CDPK1 at the parasite periphery in schizonts (panel i) and free merozoites (panel ii). The second panel shows a merged image of nuclear staining with 4',6'-diamino-2-phenylindole (blue) and the bright field image, and the third panel shows the bright field image. B, panel i, CDPK1 colocalizes with MTIP around the periphery of merozoites but is also found around the residual body, marked with an arrowhead, from which MTIP is absent. In young (panel ii) and segmented (panel iii) schizonts, CDPK1 colocalizes with the plasma membrane marker MSP1. Both proteins are also detected around the residual body, marked with an arrowhead. CDPK1 does not colocalize with the food vacuole marker PfCRT in either immature (panel iv) or mature (panel v) schizonts. The third panels in all of the images show the merged images of the antibody staining, beside which is a merged image of the bright field image and the nuclei of the parasites stained with 4',6'-diamino-2-phenylindole (blue), followed by the bright field image alone. C, both CDPK1 (red) and MSP1 (green) can be detected on residual bodies that are released upon schizont rupture. The merged images of the antibody staining are shown in the third panels, followed by the bright field image. In all cases the white scale bar in the first panel of each set of images represents 1 mum.
###end p 31
###begin p 32
###xml 0 53 0 53 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CDPK1 localizes to the plasma membrane of merozoites.</bold>
###xml 53 54 53 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 133 140 133 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel i</italic>
###xml 163 171 163 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel ii</italic>
###xml 178 190 178 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">second panel</italic>
###xml 267 271 267 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blue</italic>
###xml 351 352 351 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 354 361 354 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel i</italic>
###xml 485 494 485 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrowhead</italic>
###xml 533 541 533 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel ii</italic>
###xml 558 567 558 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel iii</italic>
###xml 709 718 709 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrowhead</italic>
###xml 801 809 801 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel iv</italic>
###xml 822 829 822 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel v</italic>
###xml 846 858 846 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink">third panels</italic>
###xml 1061 1065 1061 1065 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blue</italic>
###xml 1110 1111 1110 1111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1125 1128 1125 1128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 1140 1145 1140 1145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 1283 1295 1283 1295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">third panels</italic>
###xml 1350 1365 1350 1365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">white scale bar</italic>
CDPK1 localizes to the plasma membrane of merozoites.A, an anti-CDPK1 antibody detects CDPK1 at the parasite periphery in schizonts (panel i) and free merozoites (panel ii). The second panel shows a merged image of nuclear staining with 4',6'-diamino-2-phenylindole (blue) and the bright field image, and the third panel shows the bright field image. B, panel i, CDPK1 colocalizes with MTIP around the periphery of merozoites but is also found around the residual body, marked with an arrowhead, from which MTIP is absent. In young (panel ii) and segmented (panel iii) schizonts, CDPK1 colocalizes with the plasma membrane marker MSP1. Both proteins are also detected around the residual body, marked with an arrowhead. CDPK1 does not colocalize with the food vacuole marker PfCRT in either immature (panel iv) or mature (panel v) schizonts. The third panels in all of the images show the merged images of the antibody staining, beside which is a merged image of the bright field image and the nuclei of the parasites stained with 4',6'-diamino-2-phenylindole (blue), followed by the bright field image alone. C, both CDPK1 (red) and MSP1 (green) can be detected on residual bodies that are released upon schizont rupture. The merged images of the antibody staining are shown in the third panels, followed by the bright field image. In all cases the white scale bar in the first panel of each set of images represents 1 mum.
###end p 32
###begin p 33
###xml 194 195 194 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 188 195 188 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>A</italic></xref>
###xml 197 205 197 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panels i</italic>
###xml 210 212 210 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ii</italic>
###xml 735 736 735 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 729 736 729 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 738 745 738 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel i</italic>
###xml 942 943 930 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 936 943 924 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 945 953 933 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel ii</italic>
###xml 1096 1097 1084 1085 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1090 1097 1078 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 1099 1108 1087 1096 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel iii</italic>
###xml 1414 1415 1402 1403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1408 1415 1396 1403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 1417 1425 1405 1413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel iv</italic>
###xml 1430 1431 1418 1419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">v</italic>
###xml 1783 1785 1771 1773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref26">26</xref>
###xml 1787 1789 1775 1777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref27">27</xref>
###xml 1873 1874 1861 1862 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1867 1874 1855 1862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>C</italic></xref>
We examined the subcellular location of CDPK1 in free merozoites and schizonts by immunofluorescence. CDPK1 is present at the periphery of merozoites, both within schizonts, and released (Fig. 2A, panels i and ii, respectively). From this image we cannot distinguish between the plasma membrane and membranes of the IMC. However, dual staining of schizonts with anti-CDPK1 antibodies and antibodies raised against MTIP (a marker for the IMC) and MSP1 (a marker for the parasite plasma membrane) revealed interesting differences. CDPK1 colocalizes with MTIP around developing merozoites in segmented schizonts but is also present in membranes around the mature food vacuole/residual body of the schizonts, whereas MTIP is absent (Fig. 2B, panel i). CDPK1 and MSP1 colocalize entirely. In young schizonts (approximately39 h post-invasion) where segmentation has not begun, both CDPK1 and MSP1 are present in the parasite plasma membrane (Fig. 2B, panel ii). In more mature schizonts where segmentation is complete, both CDPK1 and MSP1 are seen in the plasma membrane around the food vacuole (Fig. 2B, panel iii). To exclude the possibility that CDPK1 is present within the food vacuole membrane, we stained parasites with antibodies against PfCRT, a known marker of the food vacuole membrane. There was no coincidence of staining in early schizonts and a small amount of colocalization in segmented schizonts (Fig. 2B, panel iv and v). We also see CDPK1and MSP1 in the membranes surrounding residual bodies, structures that consist of food vacuoles containing hemozoin that are discarded when a schizonts ruptures. Residual bodies are surrounded by parasite plasma membrane, a consequence of the mechanism by which merozoites are pinched off from the syncytium within the erythrocyte (26, 27) and therefore stain with known markers of the plasma membrane such as MSP1 (Fig. 2C).
###end p 33
###begin p 34
###xml 0 50 0 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAP45 and MTIP Are Substrates for PfCDPK1 in Vitro</italic>
###xml 272 280 272 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 352 354 352 354 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 666 668 666 668 <sub xmlns:xlink="http://www.w3.org/1999/xlink">22</sub>
###xml 740 741 740 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 734 741 734 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>A</italic></xref>
###xml 907 908 907 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 901 908 901 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>B</italic></xref>
###xml 958 961 958 961 <sup xmlns:xlink="http://www.w3.org/1999/xlink">191</sup>
###xml 1156 1158 1156 1158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref10">10</xref>
###xml 1295 1296 1295 1296 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 1294 1296 1294 1296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 1324 1325 1321 1322 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1333 1334 1330 1331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1327 1334 1324 1331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>A</italic></xref>
###xml 1342 1343 1339 1340 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 1341 1343 1338 1340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 1468 1469 1465 1466 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 1467 1469 1464 1466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 1484 1485 1478 1479 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1508 1509 1502 1503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1502 1509 1496 1503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>B</italic></xref>
###xml 1517 1518 1511 1512 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 1516 1518 1510 1512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 1570 1571 1561 1562 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1597 1598 1585 1586 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1618 1619 1606 1607 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1624 1625 1612 1613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1610 1625 1598 1613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4, <italic>C</italic> and <italic>D</italic></xref>
###xml 1684 1686 1671 1673 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 1689 1691 1676 1678 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 1741 1743 1727 1729 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 1746 1748 1732 1734 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 1959 1961 1944 1946 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 1964 1966 1949 1951 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 2061 2063 2045 2047 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 2066 2068 2050 2052 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 2077 2079 2061 2063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref10">10</xref>
###xml 674 680 <span type="species:ncbi:9913">bovine</span>
GAP45 and MTIP Are Substrates for PfCDPK1 in Vitro-Because of its close proximity to the IMC and its similar membrane anchorage to GAP45, a known component of the motor complex in the IMC, we tested the ability of recombinant CDPK1 to phosphorylate GAP45, GAP50, and MTIP in vitro. Initially, kinase assays were performed in which the incorporation of 32P from radiolabeled ATP into substrate proteins was measured. The proteins were separated by SDS-PAGE, and phosphorylation was detected by autoradiography. Both MTIP and GAP45 were efficiently phosphorylated by CDPK1, whereas another component of the motor complex, GAP50, was not. Further control proteins, MSP722, and bovine serum albumin were also not phosphorylated by CDPK1 (Fig. 3A). The absolute calcium dependence of this phosphorylation and the inability of a "kinase-dead" mutant of CDPK1 to autophosphorylate or modify MTIP is shown in Fig. 3B. The kinase-dead mutant was made by modifying Asp191 in the HRD catalytic triad of CDPK1 to Asn. We saw no effect of MTIP or GAP45 on autophosphorylation of CDPK1, in contrast to the increased autophosphorylation of CDPK1 in the presence of RKIP (10). Further coupled-enzyme kinase assays were used to determine the kinetic parameters for the enzyme substrate pairs. We determined the Km for MTIP to be 9 +/- 0.9 mum (Fig. 4A). The Km calculation for GAP45 was carried out with a somewhat restricted data set because of limiting amounts of GAP45; however, a Km of 18 +/- 5 mum was calculated (Fig. 4B). The Km of CDPK1 for ATP was calculated to be 125 +/- 13 mum for MTIP and 96 +/- 28 mum for GAP45 (Fig. 4, C and D). The activity of CDPK1 was calculated to be 0.2 mumol min-1 mg-1 enzyme with MTIP as a substrate and 0.5 mumol min-1 mg-1 enzyme with GAP45 as a substrate. Previous calculations of CDPK1 activity toward different substrates have been made. When phosphorylating the exogenous substrate casein, CDPK1 had an activity of 0.28 mumol min-1 mg-1 enzyme, whereas with the parasite protein RKIP as a substrate, the activity was 0.04 mumol min-1 mg-1 enzyme (10).
###end p 34
###begin p 35
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 3.</label>
###xml 9 48 9 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink">GAP45 and MTIP are substrates of CDPK1.</bold>
###xml 48 49 48 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 55 66 55 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upper panel</italic>
###xml 108 116 108 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 206 208 206 208 <sub xmlns:xlink="http://www.w3.org/1999/xlink">22</sub>
###xml 235 246 235 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower panel</italic>
###xml 327 329 323 325 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 777 778 761 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 889 892 873 876 <sup xmlns:xlink="http://www.w3.org/1999/xlink">191</sup>
###xml 961 977 945 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink">two upper panels</italic>
###xml 1031 1041 1015 1025 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left panel</italic>
###xml 1088 1099 1072 1083 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right panel</italic>
###xml 1128 1131 1112 1115 <sup xmlns:xlink="http://www.w3.org/1999/xlink">191</sup>
###xml 1157 1169 1141 1153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower panels</italic>
###xml 1249 1251 1229 1231 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 9 1257 9 1237 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="36"><bold>GAP45 and MTIP are substrates of CDPK1.</bold><italic>A</italic>, the <italic>upper panel</italic> shows a Coomassie Blue-stained gel of an <italic>in vitro</italic> kinase assay performed with recombinant CDPK1 and MTIP, GAP45, bovine serum albumin, MSP7<sub>22</sub>, or GAP50 substrates. The <italic>lower panel</italic> is an autoradiograph of duplicate reactions incubated in the presence of [&#947;-<sup>32</sup>P]ATP. Only MTIP and GAP45 are phosphorylated by CDPK1. In all cases we see autophosphorylation of CDPK1, except when EGTA is included in the reaction mixture. Recombinant GAP50 was treated with factor Xa to remove the 12-kDa thioredoxin tag encoded by the pET32 vector. Residual factor Xa has cleaved a proportion of the tag present on CDPK1 (&#8764;5 kDa, encoded in the pET30 vector), resulting in CDPK1 running as a doublet in this lane. <italic>B</italic>, phosphorylation of MTIP is absolutely dependent on the presence of calcium, and a substitution of Asn for Asp<sup>191</sup> in the catalytic triad of CDPK1 results in an inactive protein. The <italic>two upper panels</italic> show Coomassie-stained gels of kinase reactions; the <italic>left panel</italic> shows reactions with wild-type CDPK1, and the <italic>right panel</italic> shows reactions with the Asp<sup>191</sup> to Asn substitution. The <italic>lower panels</italic> show autoradiographs of the same reactions incubated in the presence of [&#947;-<sup>32</sup>P]ATP.</p>
###xml 9 1257 9 1237 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="36"><bold>GAP45 and MTIP are substrates of CDPK1.</bold><italic>A</italic>, the <italic>upper panel</italic> shows a Coomassie Blue-stained gel of an <italic>in vitro</italic> kinase assay performed with recombinant CDPK1 and MTIP, GAP45, bovine serum albumin, MSP7<sub>22</sub>, or GAP50 substrates. The <italic>lower panel</italic> is an autoradiograph of duplicate reactions incubated in the presence of [&#947;-<sup>32</sup>P]ATP. Only MTIP and GAP45 are phosphorylated by CDPK1. In all cases we see autophosphorylation of CDPK1, except when EGTA is included in the reaction mixture. Recombinant GAP50 was treated with factor Xa to remove the 12-kDa thioredoxin tag encoded by the pET32 vector. Residual factor Xa has cleaved a proportion of the tag present on CDPK1 (&#8764;5 kDa, encoded in the pET30 vector), resulting in CDPK1 running as a doublet in this lane. <italic>B</italic>, phosphorylation of MTIP is absolutely dependent on the presence of calcium, and a substitution of Asn for Asp<sup>191</sup> in the catalytic triad of CDPK1 results in an inactive protein. The <italic>two upper panels</italic> show Coomassie-stained gels of kinase reactions; the <italic>left panel</italic> shows reactions with wild-type CDPK1, and the <italic>right panel</italic> shows reactions with the Asp<sup>191</sup> to Asn substitution. The <italic>lower panels</italic> show autoradiographs of the same reactions incubated in the presence of [&#947;-<sup>32</sup>P]ATP.</p></caption>
###xml 1257 1257 1237 1237 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0470855330003"/>
###xml 0 1257 0 1237 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig3"><label>FIGURE 3.</label><caption><p textid="36"><bold>GAP45 and MTIP are substrates of CDPK1.</bold><italic>A</italic>, the <italic>upper panel</italic> shows a Coomassie Blue-stained gel of an <italic>in vitro</italic> kinase assay performed with recombinant CDPK1 and MTIP, GAP45, bovine serum albumin, MSP7<sub>22</sub>, or GAP50 substrates. The <italic>lower panel</italic> is an autoradiograph of duplicate reactions incubated in the presence of [&#947;-<sup>32</sup>P]ATP. Only MTIP and GAP45 are phosphorylated by CDPK1. In all cases we see autophosphorylation of CDPK1, except when EGTA is included in the reaction mixture. Recombinant GAP50 was treated with factor Xa to remove the 12-kDa thioredoxin tag encoded by the pET32 vector. Residual factor Xa has cleaved a proportion of the tag present on CDPK1 (&#8764;5 kDa, encoded in the pET30 vector), resulting in CDPK1 running as a doublet in this lane. <italic>B</italic>, phosphorylation of MTIP is absolutely dependent on the presence of calcium, and a substitution of Asn for Asp<sup>191</sup> in the catalytic triad of CDPK1 results in an inactive protein. The <italic>two upper panels</italic> show Coomassie-stained gels of kinase reactions; the <italic>left panel</italic> shows reactions with wild-type CDPK1, and the <italic>right panel</italic> shows reactions with the Asp<sup>191</sup> to Asn substitution. The <italic>lower panels</italic> show autoradiographs of the same reactions incubated in the presence of [&#947;-<sup>32</sup>P]ATP.</p></caption><graphic xlink:href="zbc0470855330003"/></fig>
###xml 180 186 <span type="species:ncbi:9913">bovine</span>
FIGURE 3.GAP45 and MTIP are substrates of CDPK1.A, the upper panel shows a Coomassie Blue-stained gel of an in vitro kinase assay performed with recombinant CDPK1 and MTIP, GAP45, bovine serum albumin, MSP722, or GAP50 substrates. The lower panel is an autoradiograph of duplicate reactions incubated in the presence of [gamma-32P]ATP. Only MTIP and GAP45 are phosphorylated by CDPK1. In all cases we see autophosphorylation of CDPK1, except when EGTA is included in the reaction mixture. Recombinant GAP50 was treated with factor Xa to remove the 12-kDa thioredoxin tag encoded by the pET32 vector. Residual factor Xa has cleaved a proportion of the tag present on CDPK1 (approximately5 kDa, encoded in the pET30 vector), resulting in CDPK1 running as a doublet in this lane. B, phosphorylation of MTIP is absolutely dependent on the presence of calcium, and a substitution of Asn for Asp191 in the catalytic triad of CDPK1 results in an inactive protein. The two upper panels show Coomassie-stained gels of kinase reactions; the left panel shows reactions with wild-type CDPK1, and the right panel shows reactions with the Asp191 to Asn substitution. The lower panels show autoradiographs of the same reactions incubated in the presence of [gamma-32P]ATP.
###end p 35
###begin p 36
###xml 0 39 0 39 <bold xmlns:xlink="http://www.w3.org/1999/xlink">GAP45 and MTIP are substrates of CDPK1.</bold>
###xml 39 40 39 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 46 57 46 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upper panel</italic>
###xml 99 107 99 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 197 199 197 199 <sub xmlns:xlink="http://www.w3.org/1999/xlink">22</sub>
###xml 226 237 226 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower panel</italic>
###xml 318 320 314 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 768 769 752 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 880 883 864 867 <sup xmlns:xlink="http://www.w3.org/1999/xlink">191</sup>
###xml 952 968 936 952 <italic xmlns:xlink="http://www.w3.org/1999/xlink">two upper panels</italic>
###xml 1022 1032 1006 1016 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left panel</italic>
###xml 1079 1090 1063 1074 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right panel</italic>
###xml 1119 1122 1103 1106 <sup xmlns:xlink="http://www.w3.org/1999/xlink">191</sup>
###xml 1148 1160 1132 1144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower panels</italic>
###xml 1240 1242 1220 1222 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 171 177 <span type="species:ncbi:9913">bovine</span>
GAP45 and MTIP are substrates of CDPK1.A, the upper panel shows a Coomassie Blue-stained gel of an in vitro kinase assay performed with recombinant CDPK1 and MTIP, GAP45, bovine serum albumin, MSP722, or GAP50 substrates. The lower panel is an autoradiograph of duplicate reactions incubated in the presence of [gamma-32P]ATP. Only MTIP and GAP45 are phosphorylated by CDPK1. In all cases we see autophosphorylation of CDPK1, except when EGTA is included in the reaction mixture. Recombinant GAP50 was treated with factor Xa to remove the 12-kDa thioredoxin tag encoded by the pET32 vector. Residual factor Xa has cleaved a proportion of the tag present on CDPK1 (approximately5 kDa, encoded in the pET30 vector), resulting in CDPK1 running as a doublet in this lane. B, phosphorylation of MTIP is absolutely dependent on the presence of calcium, and a substitution of Asn for Asp191 in the catalytic triad of CDPK1 results in an inactive protein. The two upper panels show Coomassie-stained gels of kinase reactions; the left panel shows reactions with wild-type CDPK1, and the right panel shows reactions with the Asp191 to Asn substitution. The lower panels show autoradiographs of the same reactions incubated in the presence of [gamma-32P]ATP.
###end p 36
###begin p 37
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 4.</label>
###xml 9 53 9 53 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Kinetic studies of CDPK1 and its substrates.</bold>
###xml 121 122 117 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 122 125 118 121 <sub xmlns:xlink="http://www.w3.org/1999/xlink">340</sub>
###xml 194 195 190 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 203 204 199 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 259 260 254 255 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 278 279 273 274 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 277 279 272 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 321 322 313 314 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 357 358 346 347 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 365 366 350 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 366 369 351 354 <sub xmlns:xlink="http://www.w3.org/1999/xlink">340</sub>
###xml 422 423 407 408 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 421 423 406 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 452 453 437 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 465 466 450 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 498 499 478 479 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 593 594 572 573 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 609 610 587 588 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 676 686 648 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">solid line</italic>
###xml 9 825 9 797 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="38"><bold>Kinetic studies of CDPK1 and its substrates.</bold> Enzyme-coupled kinase assays measuring the reduction in NADH (&#916;<italic>A</italic><sub>340</sub>/min) are shown for CDPK1 while varying the substrate concentration. <italic>A</italic>, MTIP; <italic>B</italic>, GAP45. The ATP concentration in both cases was 700 &#956;<sc>m</sc>. From these the <italic>K<sub>m</sub></italic> for MTIP is calculated to be 9 &#177; 0.9 &#956;<sc>m</sc>, and that for GAP45 is 18 &#177; 5 &#956;<sc>m</sc>. &#916;<italic>A</italic><sub>340</sub>/min plotted against ATP concentration, to give the <italic>K<sub>m</sub></italic> for ATP of CDPK1 with MTIP (<italic>C</italic>) or GAP45 (<italic>D</italic>) as 125 &#177; 13 and 96 &#177; 28 &#956;<sc>m</sc>, respectively. These experiments were carried out at constant substrate concentration (8.2 &#956;<sc>m</sc> MTIP or 3.5 &#956;<sc>m</sc> GAP45). In all cases data points (&#9830;) are plotted, with the <italic>solid line</italic> representing the best fit curve calculated by direct nonlinear least squares fit to the Michaelis-Menten equation using in-house software.</p>
###xml 9 825 9 797 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="38"><bold>Kinetic studies of CDPK1 and its substrates.</bold> Enzyme-coupled kinase assays measuring the reduction in NADH (&#916;<italic>A</italic><sub>340</sub>/min) are shown for CDPK1 while varying the substrate concentration. <italic>A</italic>, MTIP; <italic>B</italic>, GAP45. The ATP concentration in both cases was 700 &#956;<sc>m</sc>. From these the <italic>K<sub>m</sub></italic> for MTIP is calculated to be 9 &#177; 0.9 &#956;<sc>m</sc>, and that for GAP45 is 18 &#177; 5 &#956;<sc>m</sc>. &#916;<italic>A</italic><sub>340</sub>/min plotted against ATP concentration, to give the <italic>K<sub>m</sub></italic> for ATP of CDPK1 with MTIP (<italic>C</italic>) or GAP45 (<italic>D</italic>) as 125 &#177; 13 and 96 &#177; 28 &#956;<sc>m</sc>, respectively. These experiments were carried out at constant substrate concentration (8.2 &#956;<sc>m</sc> MTIP or 3.5 &#956;<sc>m</sc> GAP45). In all cases data points (&#9830;) are plotted, with the <italic>solid line</italic> representing the best fit curve calculated by direct nonlinear least squares fit to the Michaelis-Menten equation using in-house software.</p></caption>
###xml 825 825 797 797 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0470855330004"/>
###xml 0 825 0 797 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig4"><label>FIGURE 4.</label><caption><p textid="38"><bold>Kinetic studies of CDPK1 and its substrates.</bold> Enzyme-coupled kinase assays measuring the reduction in NADH (&#916;<italic>A</italic><sub>340</sub>/min) are shown for CDPK1 while varying the substrate concentration. <italic>A</italic>, MTIP; <italic>B</italic>, GAP45. The ATP concentration in both cases was 700 &#956;<sc>m</sc>. From these the <italic>K<sub>m</sub></italic> for MTIP is calculated to be 9 &#177; 0.9 &#956;<sc>m</sc>, and that for GAP45 is 18 &#177; 5 &#956;<sc>m</sc>. &#916;<italic>A</italic><sub>340</sub>/min plotted against ATP concentration, to give the <italic>K<sub>m</sub></italic> for ATP of CDPK1 with MTIP (<italic>C</italic>) or GAP45 (<italic>D</italic>) as 125 &#177; 13 and 96 &#177; 28 &#956;<sc>m</sc>, respectively. These experiments were carried out at constant substrate concentration (8.2 &#956;<sc>m</sc> MTIP or 3.5 &#956;<sc>m</sc> GAP45). In all cases data points (&#9830;) are plotted, with the <italic>solid line</italic> representing the best fit curve calculated by direct nonlinear least squares fit to the Michaelis-Menten equation using in-house software.</p></caption><graphic xlink:href="zbc0470855330004"/></fig>
FIGURE 4.Kinetic studies of CDPK1 and its substrates. Enzyme-coupled kinase assays measuring the reduction in NADH (DeltaA340/min) are shown for CDPK1 while varying the substrate concentration. A, MTIP; B, GAP45. The ATP concentration in both cases was 700 mum. From these the Km for MTIP is calculated to be 9 +/- 0.9 mum, and that for GAP45 is 18 +/- 5 mum. DeltaA340/min plotted against ATP concentration, to give the Km for ATP of CDPK1 with MTIP (C) or GAP45 (D) as 125 +/- 13 and 96 +/- 28 mum, respectively. These experiments were carried out at constant substrate concentration (8.2 mum MTIP or 3.5 mum GAP45). In all cases data points (diamond) are plotted, with the solid line representing the best fit curve calculated by direct nonlinear least squares fit to the Michaelis-Menten equation using in-house software.
###end p 37
###begin p 38
###xml 0 44 0 44 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Kinetic studies of CDPK1 and its substrates.</bold>
###xml 112 113 108 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 113 116 109 112 <sub xmlns:xlink="http://www.w3.org/1999/xlink">340</sub>
###xml 185 186 181 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 194 195 190 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 250 251 245 246 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 269 270 264 265 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 268 270 263 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 312 313 304 305 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 348 349 337 338 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 356 357 341 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 357 360 342 345 <sub xmlns:xlink="http://www.w3.org/1999/xlink">340</sub>
###xml 413 414 398 399 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 412 414 397 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 443 444 428 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 456 457 441 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 489 490 469 470 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 584 585 563 564 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 600 601 578 579 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 667 677 639 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink">solid line</italic>
Kinetic studies of CDPK1 and its substrates. Enzyme-coupled kinase assays measuring the reduction in NADH (DeltaA340/min) are shown for CDPK1 while varying the substrate concentration. A, MTIP; B, GAP45. The ATP concentration in both cases was 700 mum. From these the Km for MTIP is calculated to be 9 +/- 0.9 mum, and that for GAP45 is 18 +/- 5 mum. DeltaA340/min plotted against ATP concentration, to give the Km for ATP of CDPK1 with MTIP (C) or GAP45 (D) as 125 +/- 13 and 96 +/- 28 mum, respectively. These experiments were carried out at constant substrate concentration (8.2 mum MTIP or 3.5 mum GAP45). In all cases data points (diamond) are plotted, with the solid line representing the best fit curve calculated by direct nonlinear least squares fit to the Michaelis-Menten equation using in-house software.
###end p 38
###begin p 39
###xml 592 594 592 594 <sup xmlns:xlink="http://www.w3.org/1999/xlink">47</sup>
###xml 599 601 599 601 <sup xmlns:xlink="http://www.w3.org/1999/xlink">51</sup>
###xml 606 608 606 608 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 613 615 613 615 <sup xmlns:xlink="http://www.w3.org/1999/xlink">58</sup>
###xml 624 626 624 626 <sup xmlns:xlink="http://www.w3.org/1999/xlink">61</sup>
###xml 726 727 726 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 720 727 720 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>A</italic></xref>
###xml 985 986 985 986 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 979 986 979 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>B</italic></xref>
###xml 1045 1046 1045 1046 <italic xmlns:xlink="http://www.w3.org/1999/xlink">m</italic>
###xml 1047 1048 1047 1048 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z</italic>
Phosphopeptides from MTIP and GAP45 were identified by MALDI-TOF mass spectrometry. Metastable assignments were confirmed by post-source decay analysis (data not shown). Recombinant proteins were phosphorylated by CDPK1 and subjected to digestion with trypsin (MTIP) or AspN (GAP45), and phosphopeptides were enriched by purification on either gallium spin columns or TALON magnetic beads. A single peptide from MTIP was detected, KPLSIEESFENSEESEES-VADIQQLEEK, which spans amino acids 44-71 in the MTIP sequence. The peptides were isolated in which either one or two of the five serines (Ser47, Ser51, Ser55, Ser58, and Ser61) were phosphorylated, along with their metastable products, because of phosphoric acid loss (Fig. 5A). For GAP45, two phosphopeptides and their metastable products were identified, each containing a single phosphorylated residue. The GAP45 phosphopeptides are DYATQENKSFEEKHLE and DLERSNSDIYSESQKF, spanning amino acids 81-96 and 97-112, respectively (Fig. 5B). The GAP45 spectrum also shows a phosphorylated peptide (m/z 1934.829) that is derived from the vector tag of pQE60.
###end p 39
###begin p 40
###xml 299 301 299 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 381 382 381 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 375 382 375 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>C</italic></xref>
###xml 531 533 531 533 <sup xmlns:xlink="http://www.w3.org/1999/xlink">47</sup>
###xml 540 542 540 542 <sup xmlns:xlink="http://www.w3.org/1999/xlink">51</sup>
###xml 602 604 602 604 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 685 687 685 687 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 806 808 806 808 <sup xmlns:xlink="http://www.w3.org/1999/xlink">47</sup>
###xml 881 883 881 883 <sup xmlns:xlink="http://www.w3.org/1999/xlink">51</sup>
To identify the specific serine residues in MTIP that are phosphorylated by CDPK1, recombinant MTIP proteins were made where serine residues 47, 51, 55, 58, and 61 were individually mutated to alanine by site-directed mutagenesis. Radio-metric kinase assays were performed, and the incorporation of 32P into the proteins was compared with that of the wild-type MTIP protein (Fig. 5C). Substitution of serines 55, 58, and 61 did not result in a significant reduction in phosphorylation of MTIP by CDPK1. In contrast, mutation of Ser47 or Ser51 resulted in a 73 and 34% reduction in the incorporation of 32P, respectively. When a double S47A/S51A mutant of MTIP was used, a reduction of 32P incorporation of 90% was observed. These data suggest that the primary phosphorylation of MTIP by CDPK1 occurs on Ser47, with a secondary phosphorylation occurring nonstoichiometrically on Ser51. Because the signal in the assay did not drop to zero when the S47A/S51A MTIP mutant was used, it would seem that there is a third site in MTIP that is phosphorylated at a much lower efficiency that remains unidentified.
###end p 40
###begin p 41
###xml 0 50 0 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MTIP and GAP45 Are Phosphoproteins in the Parasite</italic>
###xml 330 331 330 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 324 331 324 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6<italic>A</italic></xref>
###xml 333 340 333 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel i</italic>
###xml 449 450 449 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 443 450 443 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6<italic>A</italic></xref>
###xml 452 460 452 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel ii</italic>
###xml 634 635 634 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 628 635 628 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6<italic>A</italic></xref>
###xml 637 646 637 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel iii</italic>
###xml 719 720 719 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 713 720 713 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6<italic>A</italic></xref>
###xml 722 730 722 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel iv</italic>
###xml 1337 1338 1337 1338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1331 1338 1331 1338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6<italic>B</italic></xref>
###xml 1340 1347 1340 1347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel i</italic>
###xml 1463 1469 1463 1469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">versus</italic>
###xml 1541 1542 1541 1542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1535 1542 1535 1542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6<italic>B</italic></xref>
###xml 1544 1553 1544 1553 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel iii</italic>
###xml 1558 1560 1558 1560 <italic xmlns:xlink="http://www.w3.org/1999/xlink">iv</italic>
###xml 1706 1707 1706 1707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1700 1707 1700 1707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6<italic>B</italic></xref>
###xml 1709 1717 1709 1717 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel ii</italic>
MTIP and GAP45 Are Phosphoproteins in the Parasite-It is crucial to establish that both GAP45 and MTIP are phosphorylated in parasites. To this end, schizont extracts were separated by two-dimensional SDS-PAGE and then immunoblotted with antibodies to either MTIP or GAP45. MTIP migrates as two spots that differ in charge (Fig. 6A, panel i). When phosphate groups were removed by treating the lysate with SAP, MTIP migrates as a single spot (Fig. 6A, panel ii). When the same extracts were probed using an anti-GAP45 antibody, GAP45 was identified as three spots that differ in both mass and charge in the mock treated lysate (Fig. 6A, panel iii). In SAP-treated samples GAP45 also migrates as a single species (Fig. 6A, panel iv). We further examined the phosphorylation of GAP45 during parasite development. Cell lysates from parasites ranging from late trophozoite (33 h post-invasion) to late schizont stages (45 h post-invasion) were separated by one-dimensional SDS-PAGE and blotted with an anti-GAP45 antibody. Expression of GAP45 is just detectable at early time points, and its expression peaks at 45 h post-invasion, where it migrates as a doublet. The upper band (containing phosphorylated GAP45) increases in intensity in relation to the lower band (nonphosphorylated GAP45) as development of the parasite progresses (Fig. 6B, panel i). If the amount of protein loaded is adjusted to normalize GAP45 levels, the relative proportion of phosphorylated versus nonphosphorylated GAP45 at a given time point can be calculated (Fig. 6B, panel iii and iv). The proportion of phosphorylated GAP45 increases from 12% at 33 h to 62% at 45 h. This increase mirrors the expression profile of CDPK1 (Fig. 6B, panel ii).
###end p 41
###begin p 42
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 5.</label>
###xml 9 69 9 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Analysis of phosphopeptides from recombinant MTIP and GAP45.</bold>
###xml 69 70 69 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 239 240 239 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 437 438 437 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 457 459 457 459 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 539 547 539 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 599 601 599 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT</italic>
###xml 627 629 627 629 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 729 731 729 731 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 736 738 736 738 <sup xmlns:xlink="http://www.w3.org/1999/xlink">58</sup>
###xml 747 749 747 749 <sup xmlns:xlink="http://www.w3.org/1999/xlink">61</sup>
###xml 796 798 796 798 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 9 872 9 872 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="43"><bold>Analysis of phosphopeptides from recombinant MTIP and GAP45.</bold><italic>A</italic>, MTIP tryptic peptides eluted from TALON magnetic beads. A single peptide is seen, with either one or two phosphates, along with metastable post-source decay products. <italic>B</italic>, phosphopeptides of GAP45 eluted from a gallium spin column. Three phosphopeptides are detected. Peptide 1 is derived from the vector-encoded protein tag, whereas peptides 2 and 3 are from GAP45. <italic>C</italic>, incorporation of <sup>32</sup>P into MTIP mutants was measured by scanning densitometry of autoradiographs of <italic>in vitro</italic> kinase assays and compared with wild-type protein (<italic>WT</italic>). The S47A mutant showed <sup>32</sup>P incorporation of 27%, the and S51A mutant showed 66% compared with wild-type MTIP. Mutation of Ser<sup>55</sup>, Ser<sup>58</sup>, and Ser<sup>61</sup> did not significantly affect incorporation of <sup>32</sup>P. A double mutant (S47A/S51A) gave a signal of 10% compared with WT MTIP.</p>
###xml 9 872 9 872 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="43"><bold>Analysis of phosphopeptides from recombinant MTIP and GAP45.</bold><italic>A</italic>, MTIP tryptic peptides eluted from TALON magnetic beads. A single peptide is seen, with either one or two phosphates, along with metastable post-source decay products. <italic>B</italic>, phosphopeptides of GAP45 eluted from a gallium spin column. Three phosphopeptides are detected. Peptide 1 is derived from the vector-encoded protein tag, whereas peptides 2 and 3 are from GAP45. <italic>C</italic>, incorporation of <sup>32</sup>P into MTIP mutants was measured by scanning densitometry of autoradiographs of <italic>in vitro</italic> kinase assays and compared with wild-type protein (<italic>WT</italic>). The S47A mutant showed <sup>32</sup>P incorporation of 27%, the and S51A mutant showed 66% compared with wild-type MTIP. Mutation of Ser<sup>55</sup>, Ser<sup>58</sup>, and Ser<sup>61</sup> did not significantly affect incorporation of <sup>32</sup>P. A double mutant (S47A/S51A) gave a signal of 10% compared with WT MTIP.</p></caption>
###xml 872 872 872 872 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0470855330005"/>
###xml 0 872 0 872 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig5"><label>FIGURE 5.</label><caption><p textid="43"><bold>Analysis of phosphopeptides from recombinant MTIP and GAP45.</bold><italic>A</italic>, MTIP tryptic peptides eluted from TALON magnetic beads. A single peptide is seen, with either one or two phosphates, along with metastable post-source decay products. <italic>B</italic>, phosphopeptides of GAP45 eluted from a gallium spin column. Three phosphopeptides are detected. Peptide 1 is derived from the vector-encoded protein tag, whereas peptides 2 and 3 are from GAP45. <italic>C</italic>, incorporation of <sup>32</sup>P into MTIP mutants was measured by scanning densitometry of autoradiographs of <italic>in vitro</italic> kinase assays and compared with wild-type protein (<italic>WT</italic>). The S47A mutant showed <sup>32</sup>P incorporation of 27%, the and S51A mutant showed 66% compared with wild-type MTIP. Mutation of Ser<sup>55</sup>, Ser<sup>58</sup>, and Ser<sup>61</sup> did not significantly affect incorporation of <sup>32</sup>P. A double mutant (S47A/S51A) gave a signal of 10% compared with WT MTIP.</p></caption><graphic xlink:href="zbc0470855330005"/></fig>
FIGURE 5.Analysis of phosphopeptides from recombinant MTIP and GAP45.A, MTIP tryptic peptides eluted from TALON magnetic beads. A single peptide is seen, with either one or two phosphates, along with metastable post-source decay products. B, phosphopeptides of GAP45 eluted from a gallium spin column. Three phosphopeptides are detected. Peptide 1 is derived from the vector-encoded protein tag, whereas peptides 2 and 3 are from GAP45. C, incorporation of 32P into MTIP mutants was measured by scanning densitometry of autoradiographs of in vitro kinase assays and compared with wild-type protein (WT). The S47A mutant showed 32P incorporation of 27%, the and S51A mutant showed 66% compared with wild-type MTIP. Mutation of Ser55, Ser58, and Ser61 did not significantly affect incorporation of 32P. A double mutant (S47A/S51A) gave a signal of 10% compared with WT MTIP.
###end p 42
###begin p 43
###xml 0 60 0 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Analysis of phosphopeptides from recombinant MTIP and GAP45.</bold>
###xml 60 61 60 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 230 231 230 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 428 429 428 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 448 450 448 450 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 530 538 530 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 590 592 590 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT</italic>
###xml 618 620 618 620 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 720 722 720 722 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 727 729 727 729 <sup xmlns:xlink="http://www.w3.org/1999/xlink">58</sup>
###xml 738 740 738 740 <sup xmlns:xlink="http://www.w3.org/1999/xlink">61</sup>
###xml 787 789 787 789 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
Analysis of phosphopeptides from recombinant MTIP and GAP45.A, MTIP tryptic peptides eluted from TALON magnetic beads. A single peptide is seen, with either one or two phosphates, along with metastable post-source decay products. B, phosphopeptides of GAP45 eluted from a gallium spin column. Three phosphopeptides are detected. Peptide 1 is derived from the vector-encoded protein tag, whereas peptides 2 and 3 are from GAP45. C, incorporation of 32P into MTIP mutants was measured by scanning densitometry of autoradiographs of in vitro kinase assays and compared with wild-type protein (WT). The S47A mutant showed 32P incorporation of 27%, the and S51A mutant showed 66% compared with wild-type MTIP. Mutation of Ser55, Ser58, and Ser61 did not significantly affect incorporation of 32P. A double mutant (S47A/S51A) gave a signal of 10% compared with WT MTIP.
###end p 43
###begin p 44
###xml 0 69 0 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAP45 Phosphorylation in Parasites: Identification of Phosphopeptides</italic>
###xml 423 424 423 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 417 424 417 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7<italic>A</italic></xref>
###xml 517 518 517 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 511 518 511 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7<italic>B</italic></xref>
###xml 588 596 588 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
GAP45 Phosphorylation in Parasites: Identification of Phosphopeptides-GAP45 was purified from merozoites using an anti-GAP45 antibody affinity column. Purified protein was excised from an SDS-PAGE gel and digested with either AspN or trypsin, and the resultant peptides were analyzed by MALDI-TOF to identify phosphorylated peptides. Two phosphopeptides were identified: DYATQENKSFEEKHLE in the AspN digested sample (Fig. 7A) and an additional tryptic peptide LSEPAHEESIYFTYR corresponding to residues 141-155 (Fig. 7B). The AspN peptide is identical to one of the peptides identified in in vitro phosphorylation of GAP45 by CDPK1. The detection of a phosphopeptide in parasite-derived GAP45 that was absent from the tryptic digest of recombinant GAP45 phosphorylated by CDPK1 (data not shown) is strong evidence that an as yet unidentified parasite protein kinase phosphorylates this site.
###end p 44
###begin p 45
###xml 0 51 0 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Inhibition of CDPK1 by the Bisindolocarbazole K252a</italic>
###xml 113 122 113 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T. gondii</italic>
###xml 235 237 235 237 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 266 267 254 255 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 269 271 257 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 329 342 317 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum</italic>
###xml 414 422 402 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 464 472 452 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 484 486 472 474 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 494 495 482 483 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 497 510 485 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum</italic>
###xml 613 614 600 601 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 890 891 876 877 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1151 1152 1137 1138 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1154 1160 1140 1146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8</xref>
###xml 113 122 <span type="species:ncbi:5811">T. gondii</span>
###xml 329 342 <span type="species:ncbi:5833">P. falciparum</span>
###xml 497 510 <span type="species:ncbi:5833">P. falciparum</span>
Inhibition of CDPK1 by the Bisindolocarbazole K252a-The effect of the kinase inhibitor KT5926 has been tested in T. gondii. The inhibitor blocked attachment of parasites to host cells and reduced the activity of TgCDPK1 with similar IC50 values of approximately100 nm (11). We tested the effect of a related inhibitor, K252a, on P. falciparum cultures and on the ability of CDPK1 to phosphorylate recombinant MTIP in vitro. K252a potently inhibited CDPK1 activity in vitro, with an IC50 of 45 nm. P. falciparum invasion of erythrocytes was inhibited in the presence of K252a. At very high concentrations (0.8-5 mum) invasion of erythrocytes was completely blocked. On examination of Giemsa-stained smears of the culture, it was clear that the egress of merozoites from schizonts was blocked rather than invasion of erythrocytes by merozoites. At intermediate concentrations of K252a (0.4 mum), invasion was inhibited by 65%. At these intermediate concentrations of K252a, egress of merozoites from schizonts was not prevented; however, invasion of erythrocytes by merozoites was significantly inhibited, with half-maximal inhibition occurring at 348 nm (Fig. 8).
###end p 45
###begin title 46
DISCUSSION
###end title 46
###begin p 47
###xml 516 518 516 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref28">28</xref>
###xml 520 522 520 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref29">29</xref>
###xml 1172 1173 1172 1173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 1611 1613 1611 1613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref30">30</xref>
###xml 1825 1827 1825 1827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref13">13</xref>
###xml 2001 2003 2001 2003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 2005 2007 2005 2007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref31">31</xref>
###xml 1020 1023 <span type="species:ncbi:11263?0.47540983606557374|species:ncbi:12167?0.09016393442622951">PVM</span>
###xml 1167 1170 <span type="species:ncbi:11263?0.47540983606557374|species:ncbi:12167?0.09016393442622951">PVM</span>
We have shown that CDPK1 is present in both schizonts and free merozoites in a membrane-bound fraction, which is consistent with the dual acylation of the protein. The protein is located at the plasma membrane of the developing intracellular schizont both before and after segmentation as indicated by colocalization with MSP1. In segmenters it can be detected on the plasma membrane that surrounds the food vacuole, which is identified by the presence of the hemozoin pigment and reactivity with antibodies to CRT (28, 29). Notably, MTIP, a marker for the IMC, is absent from this membrane. Following schizont rupture and release of merozoites, the protein is still detected at the periphery of the discarded residual body derived from the food vacuole but most importantly is located at the periphery of the free merozoite. In free merozoites we cannot exclude that it is also present on other peripheral membranes, particularly the IMC. It has previously been proposed that CDPK1 is exported from the schizont to the PVM of the intracellular parasite, which would require transfer of this protein across the parasite plasma membrane followed by insertion into the PVM (8). Although we cannot exclude that this transfer occurs, our results indicate that CDPK1 is largely present in a membrane bound form at the periphery of both schizonts and free merozoites. We suggest therefore that in free merozoites the protein is located in the space between the plasma membrane (PM) and the inner membrane complex (IMC), which is the location of the actomyosin motor that drives merozoite invasion of red blood cells (30). The dual acylation of CDPK1 is sufficient to retain it at the membrane, and this post-translational modification is identical to that of GAP45, which is also myristoylated and palmitoylated at the N terminus (13). It is noteworthy that GAP45, which is a component of the motor complex, is thought to be located in the space between the IMC and the PM but attached to the IMC membrane (12, 31); it may be that CDPK1 can be associated with both the inner face of the PM and the outer face of the IMC.
###end p 47
###begin p 48
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 6.</label>
###xml 9 60 9 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink">GAP45 and MTIP are phosphoproteins in the parasite.</bold>
###xml 60 61 60 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 254 262 254 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel ii</italic>
###xml 275 283 275 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel iv</italic>
###xml 393 400 393 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel i</italic>
###xml 442 451 442 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel iii</italic>
###xml 520 527 520 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">circled</italic>
###xml 531 539 531 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panels i</italic>
###xml 544 547 544 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">iii</italic>
###xml 549 550 549 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 635 642 635 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel i</italic>
###xml 671 679 671 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel ii</italic>
###xml 682 691 682 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Panel iii</italic>
###xml 809 819 809 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upper band</italic>
###xml 904 912 904 912 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Panel iv</italic>
###xml 1123 1133 1123 1133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">error bars</italic>
###xml 9 1179 9 1179 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="49"><bold>GAP45 and MTIP are phosphoproteins in the parasite.</bold><italic>A</italic>, protein extracted from late-stage schizonts was subjected to treatment with SAP, separated by two-dimensional SDS-PAGE and Western blotted with anti-MTIP or anti-GAP45 antibodies. Both MTIP (<italic>panel ii</italic>) and GAP45 (<italic>panel iv</italic>) antibodies detect only a single spot. In mock-treated samples, two spots are visible in the anti-MTIP blot (<italic>panel i</italic>) and three spots in the anti-GAP45 blot (<italic>panel iii</italic>). The phosphorylated proteins that disappear upon SAP treatment are <italic>circled</italic> in <italic>panels i</italic> and <italic>iii</italic>. <italic>B</italic>, lysates from a developmental time-course of parasites were probed with anti-GAP45 (<italic>panel i</italic>) and anti-CDPK1 antibodies (<italic>panel ii</italic>). <italic>Panel iii</italic>, loading of lysates normalized according to GAP45 levels shows that the relative proportion of phosphorylated GAP45 (<italic>upper band</italic>) increases compared with unphosphorylated GAP45 as parasite development progresses. <italic>Panel iv</italic>, scanning densitometry of anti-GAP45 immunoblots showing the proportion of phosphorylated and unphosphorylated GAP45 at each developmental time point. Each value represents the average of two experiments, with <italic>error bars</italic> showing one standard deviation from the mean.</p>
###xml 9 1179 9 1179 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="49"><bold>GAP45 and MTIP are phosphoproteins in the parasite.</bold><italic>A</italic>, protein extracted from late-stage schizonts was subjected to treatment with SAP, separated by two-dimensional SDS-PAGE and Western blotted with anti-MTIP or anti-GAP45 antibodies. Both MTIP (<italic>panel ii</italic>) and GAP45 (<italic>panel iv</italic>) antibodies detect only a single spot. In mock-treated samples, two spots are visible in the anti-MTIP blot (<italic>panel i</italic>) and three spots in the anti-GAP45 blot (<italic>panel iii</italic>). The phosphorylated proteins that disappear upon SAP treatment are <italic>circled</italic> in <italic>panels i</italic> and <italic>iii</italic>. <italic>B</italic>, lysates from a developmental time-course of parasites were probed with anti-GAP45 (<italic>panel i</italic>) and anti-CDPK1 antibodies (<italic>panel ii</italic>). <italic>Panel iii</italic>, loading of lysates normalized according to GAP45 levels shows that the relative proportion of phosphorylated GAP45 (<italic>upper band</italic>) increases compared with unphosphorylated GAP45 as parasite development progresses. <italic>Panel iv</italic>, scanning densitometry of anti-GAP45 immunoblots showing the proportion of phosphorylated and unphosphorylated GAP45 at each developmental time point. Each value represents the average of two experiments, with <italic>error bars</italic> showing one standard deviation from the mean.</p></caption>
###xml 1179 1179 1179 1179 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0470855330006"/>
###xml 0 1179 0 1179 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig6"><label>FIGURE 6.</label><caption><p textid="49"><bold>GAP45 and MTIP are phosphoproteins in the parasite.</bold><italic>A</italic>, protein extracted from late-stage schizonts was subjected to treatment with SAP, separated by two-dimensional SDS-PAGE and Western blotted with anti-MTIP or anti-GAP45 antibodies. Both MTIP (<italic>panel ii</italic>) and GAP45 (<italic>panel iv</italic>) antibodies detect only a single spot. In mock-treated samples, two spots are visible in the anti-MTIP blot (<italic>panel i</italic>) and three spots in the anti-GAP45 blot (<italic>panel iii</italic>). The phosphorylated proteins that disappear upon SAP treatment are <italic>circled</italic> in <italic>panels i</italic> and <italic>iii</italic>. <italic>B</italic>, lysates from a developmental time-course of parasites were probed with anti-GAP45 (<italic>panel i</italic>) and anti-CDPK1 antibodies (<italic>panel ii</italic>). <italic>Panel iii</italic>, loading of lysates normalized according to GAP45 levels shows that the relative proportion of phosphorylated GAP45 (<italic>upper band</italic>) increases compared with unphosphorylated GAP45 as parasite development progresses. <italic>Panel iv</italic>, scanning densitometry of anti-GAP45 immunoblots showing the proportion of phosphorylated and unphosphorylated GAP45 at each developmental time point. Each value represents the average of two experiments, with <italic>error bars</italic> showing one standard deviation from the mean.</p></caption><graphic xlink:href="zbc0470855330006"/></fig>
FIGURE 6.GAP45 and MTIP are phosphoproteins in the parasite.A, protein extracted from late-stage schizonts was subjected to treatment with SAP, separated by two-dimensional SDS-PAGE and Western blotted with anti-MTIP or anti-GAP45 antibodies. Both MTIP (panel ii) and GAP45 (panel iv) antibodies detect only a single spot. In mock-treated samples, two spots are visible in the anti-MTIP blot (panel i) and three spots in the anti-GAP45 blot (panel iii). The phosphorylated proteins that disappear upon SAP treatment are circled in panels i and iii. B, lysates from a developmental time-course of parasites were probed with anti-GAP45 (panel i) and anti-CDPK1 antibodies (panel ii). Panel iii, loading of lysates normalized according to GAP45 levels shows that the relative proportion of phosphorylated GAP45 (upper band) increases compared with unphosphorylated GAP45 as parasite development progresses. Panel iv, scanning densitometry of anti-GAP45 immunoblots showing the proportion of phosphorylated and unphosphorylated GAP45 at each developmental time point. Each value represents the average of two experiments, with error bars showing one standard deviation from the mean.
###end p 48
###begin p 49
###xml 0 51 0 51 <bold xmlns:xlink="http://www.w3.org/1999/xlink">GAP45 and MTIP are phosphoproteins in the parasite.</bold>
###xml 51 52 51 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 245 253 245 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel ii</italic>
###xml 266 274 266 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel iv</italic>
###xml 384 391 384 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel i</italic>
###xml 433 442 433 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel iii</italic>
###xml 511 518 511 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">circled</italic>
###xml 522 530 522 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panels i</italic>
###xml 535 538 535 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink">iii</italic>
###xml 540 541 540 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 626 633 626 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel i</italic>
###xml 662 670 662 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel ii</italic>
###xml 673 682 673 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Panel iii</italic>
###xml 800 810 800 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upper band</italic>
###xml 895 903 895 903 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Panel iv</italic>
###xml 1114 1124 1114 1124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">error bars</italic>
GAP45 and MTIP are phosphoproteins in the parasite.A, protein extracted from late-stage schizonts was subjected to treatment with SAP, separated by two-dimensional SDS-PAGE and Western blotted with anti-MTIP or anti-GAP45 antibodies. Both MTIP (panel ii) and GAP45 (panel iv) antibodies detect only a single spot. In mock-treated samples, two spots are visible in the anti-MTIP blot (panel i) and three spots in the anti-GAP45 blot (panel iii). The phosphorylated proteins that disappear upon SAP treatment are circled in panels i and iii. B, lysates from a developmental time-course of parasites were probed with anti-GAP45 (panel i) and anti-CDPK1 antibodies (panel ii). Panel iii, loading of lysates normalized according to GAP45 levels shows that the relative proportion of phosphorylated GAP45 (upper band) increases compared with unphosphorylated GAP45 as parasite development progresses. Panel iv, scanning densitometry of anti-GAP45 immunoblots showing the proportion of phosphorylated and unphosphorylated GAP45 at each developmental time point. Each value represents the average of two experiments, with error bars showing one standard deviation from the mean.
###end p 49
###begin p 50
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 7.</label>
###xml 9 93 9 93 <bold xmlns:xlink="http://www.w3.org/1999/xlink">MALDI-TOF analysis of phosphopeptides from affinity-purified parasite-derived GAP45.</bold>
###xml 111 112 111 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 156 157 156 157 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 159 160 159 160 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 161 162 161 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 185 186 185 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 238 239 238 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 9 241 9 241 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="51"><bold>MALDI-TOF analysis of phosphopeptides from affinity-purified parasite-derived GAP45.</bold> Phosphopeptides (<italic>p</italic>) and their post-source decay products ([M-H<sub>3</sub>PO<sub>4</sub>]<sup>+</sup>) from AspN digestion (<italic>A</italic>) and trypsin digestion of merozoite-derived GAP45 (<italic>B</italic>).</p>
###xml 9 241 9 241 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="51"><bold>MALDI-TOF analysis of phosphopeptides from affinity-purified parasite-derived GAP45.</bold> Phosphopeptides (<italic>p</italic>) and their post-source decay products ([M-H<sub>3</sub>PO<sub>4</sub>]<sup>+</sup>) from AspN digestion (<italic>A</italic>) and trypsin digestion of merozoite-derived GAP45 (<italic>B</italic>).</p></caption>
###xml 241 241 241 241 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0470855330007"/>
###xml 0 241 0 241 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig7"><label>FIGURE 7.</label><caption><p textid="51"><bold>MALDI-TOF analysis of phosphopeptides from affinity-purified parasite-derived GAP45.</bold> Phosphopeptides (<italic>p</italic>) and their post-source decay products ([M-H<sub>3</sub>PO<sub>4</sub>]<sup>+</sup>) from AspN digestion (<italic>A</italic>) and trypsin digestion of merozoite-derived GAP45 (<italic>B</italic>).</p></caption><graphic xlink:href="zbc0470855330007"/></fig>
FIGURE 7.MALDI-TOF analysis of phosphopeptides from affinity-purified parasite-derived GAP45. Phosphopeptides (p) and their post-source decay products ([M-H3PO4]+) from AspN digestion (A) and trypsin digestion of merozoite-derived GAP45 (B).
###end p 50
###begin p 51
###xml 0 84 0 84 <bold xmlns:xlink="http://www.w3.org/1999/xlink">MALDI-TOF analysis of phosphopeptides from affinity-purified parasite-derived GAP45.</bold>
###xml 102 103 102 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 147 148 147 148 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 150 151 150 151 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 152 153 152 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 176 177 176 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 229 230 229 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
MALDI-TOF analysis of phosphopeptides from affinity-purified parasite-derived GAP45. Phosphopeptides (p) and their post-source decay products ([M-H3PO4]+) from AspN digestion (A) and trypsin digestion of merozoite-derived GAP45 (B).
###end p 51
###begin p 52
###xml 590 591 590 591 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 589 591 589 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 677 678 677 678 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 676 678 676 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 688 689 685 686 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 716 717 713 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref1">1</xref>
###xml 868 870 864 866 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 873 875 869 871 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 982 984 977 979 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 987 989 982 984 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 999 1001 994 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref10">10</xref>
###xml 1028 1041 1023 1036 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum</italic>
###xml 1028 1041 <span type="species:ncbi:5833">P. falciparum</span>
We have expressed and purified active CDPK1 from recombinant bacteria. The activity has an absolute requirement for calcium, and the inactivity of the kinase-dead form of the protein resulting from replacement of Asp by Asn in the active site is consistent with the detected kinase activity being attributable to CDPK1. Of particular interest is that the enzyme can phosphorylate two proteins of the motor complex, MTIP and GAP45, whereas a third component of the complex, GAP50 and other control proteins, are not modified by CDPK1. Both MTIP and GAP45 are good substrates for CDPK1 with Km values in the low micromolar range that is well within the suggested threshold of a Km </= 50 mum for potential substrates (1). Similarly the activity of CDPK1 with both MTIP and GAP45 is in the same range as its activity with the exogenous substrate casein (0.2-0.5 mumol min-1 mg-1 enzyme) and well above the reported activity with the parasite protein RKIP as a substrate (0.04 mumol min-1 mg-1 enzyme) (10). These data confirm that P. falciparum CDPK1 is a calcium-dependent protein kinase and show that two components of the merozoite motor complex, MTIP and GAP45, are good substrates for phosphorylation. Both MTIP and GAP45 are located in the same cytoplasmic location as CDPK1, between the PM and the IMC.
###end p 52
###begin p 53
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 8.</label>
###xml 9 60 9 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Inhibition of CDPK1 and parasite invasion by K252a.</bold>
###xml 60 61 60 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 165 167 165 167 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 208 209 208 209 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 211 212 211 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 321 322 321 322 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 418 428 418 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">error bars</italic>
###xml 9 474 9 474 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="54"><bold>Inhibition of CDPK1 and parasite invasion by K252a.</bold><italic>A</italic>, CDPK1 activity on recombinant MTIP in the presence of K252a was assayed using radiolabeled ATP. The IC<sub>50</sub> for the enzyme was calculated to be 45 n<sc>m</sc>. <italic>B</italic>, the rate of invasion of parasites treated with K252a. Half-maximal inhibition of invasion occurred at 348 n<sc>m</sc> K252a. In both graphs, the values plotted are the averages of triplicate experiments, with the <italic>error bars</italic> showing one standard deviation from the mean.</p>
###xml 9 474 9 474 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="54"><bold>Inhibition of CDPK1 and parasite invasion by K252a.</bold><italic>A</italic>, CDPK1 activity on recombinant MTIP in the presence of K252a was assayed using radiolabeled ATP. The IC<sub>50</sub> for the enzyme was calculated to be 45 n<sc>m</sc>. <italic>B</italic>, the rate of invasion of parasites treated with K252a. Half-maximal inhibition of invasion occurred at 348 n<sc>m</sc> K252a. In both graphs, the values plotted are the averages of triplicate experiments, with the <italic>error bars</italic> showing one standard deviation from the mean.</p></caption>
###xml 474 474 474 474 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0470855330008"/>
###xml 0 474 0 474 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig8"><label>FIGURE 8.</label><caption><p textid="54"><bold>Inhibition of CDPK1 and parasite invasion by K252a.</bold><italic>A</italic>, CDPK1 activity on recombinant MTIP in the presence of K252a was assayed using radiolabeled ATP. The IC<sub>50</sub> for the enzyme was calculated to be 45 n<sc>m</sc>. <italic>B</italic>, the rate of invasion of parasites treated with K252a. Half-maximal inhibition of invasion occurred at 348 n<sc>m</sc> K252a. In both graphs, the values plotted are the averages of triplicate experiments, with the <italic>error bars</italic> showing one standard deviation from the mean.</p></caption><graphic xlink:href="zbc0470855330008"/></fig>
FIGURE 8.Inhibition of CDPK1 and parasite invasion by K252a.A, CDPK1 activity on recombinant MTIP in the presence of K252a was assayed using radiolabeled ATP. The IC50 for the enzyme was calculated to be 45 nm. B, the rate of invasion of parasites treated with K252a. Half-maximal inhibition of invasion occurred at 348 nm K252a. In both graphs, the values plotted are the averages of triplicate experiments, with the error bars showing one standard deviation from the mean.
###end p 53
###begin p 54
###xml 0 51 0 51 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Inhibition of CDPK1 and parasite invasion by K252a.</bold>
###xml 51 52 51 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 156 158 156 158 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 199 200 199 200 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 202 203 202 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 312 313 312 313 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 409 419 409 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">error bars</italic>
Inhibition of CDPK1 and parasite invasion by K252a.A, CDPK1 activity on recombinant MTIP in the presence of K252a was assayed using radiolabeled ATP. The IC50 for the enzyme was calculated to be 45 nm. B, the rate of invasion of parasites treated with K252a. Half-maximal inhibition of invasion occurred at 348 nm K252a. In both graphs, the values plotted are the averages of triplicate experiments, with the error bars showing one standard deviation from the mean.
###end p 54
###begin p 55
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 9.</label>
###xml 9 37 9 37 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CDPK1 and the motor complex.</bold>
###xml 9 313 9 313 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="56"><bold>CDPK1 and the motor complex.</bold> After activation by calcium, plasma membrane associated CDPK1 phosphorylates GAP45 and MTIP. GAP45 is directly associated with the outer membrane of the IMC, in a complex with MTIP, GAP50, and myosin A. GAP45 is further phosphorylated by an unidentified kinase in merozoites.</p>
###xml 9 313 9 313 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="56"><bold>CDPK1 and the motor complex.</bold> After activation by calcium, plasma membrane associated CDPK1 phosphorylates GAP45 and MTIP. GAP45 is directly associated with the outer membrane of the IMC, in a complex with MTIP, GAP50, and myosin A. GAP45 is further phosphorylated by an unidentified kinase in merozoites.</p></caption>
###xml 313 313 313 313 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0470855330009"/>
###xml 0 313 0 313 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig9"><label>FIGURE 9.</label><caption><p textid="56"><bold>CDPK1 and the motor complex.</bold> After activation by calcium, plasma membrane associated CDPK1 phosphorylates GAP45 and MTIP. GAP45 is directly associated with the outer membrane of the IMC, in a complex with MTIP, GAP50, and myosin A. GAP45 is further phosphorylated by an unidentified kinase in merozoites.</p></caption><graphic xlink:href="zbc0470855330009"/></fig>
FIGURE 9.CDPK1 and the motor complex. After activation by calcium, plasma membrane associated CDPK1 phosphorylates GAP45 and MTIP. GAP45 is directly associated with the outer membrane of the IMC, in a complex with MTIP, GAP50, and myosin A. GAP45 is further phosphorylated by an unidentified kinase in merozoites.
###end p 55
###begin p 56
###xml 0 28 0 28 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CDPK1 and the motor complex.</bold>
CDPK1 and the motor complex. After activation by calcium, plasma membrane associated CDPK1 phosphorylates GAP45 and MTIP. GAP45 is directly associated with the outer membrane of the IMC, in a complex with MTIP, GAP50, and myosin A. GAP45 is further phosphorylated by an unidentified kinase in merozoites.
###end p 56
###begin p 57
###xml 142 150 142 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 545 547 545 547 <sup xmlns:xlink="http://www.w3.org/1999/xlink">47</sup>
###xml 584 586 584 586 <sup xmlns:xlink="http://www.w3.org/1999/xlink">51</sup>
###xml 991 993 991 993 <sup xmlns:xlink="http://www.w3.org/1999/xlink">89</sup>
To examine the phosphorylation of MTIP and GAP45 further, we studied the sites of modification by CDPK1 of the recombinant expressed proteins in vitro by peptide digestion and analysis by mass spectrometry. Bioinformatic predictions suggest that many residues in both MTIP and GAP45 are capable of being phosphorylated by serine-threonine protein kinases. We identified experimentally one peptide from MTIP containing five serines that was phosphorylated once or twice and by mutagenesis have shown that the primary phosphorylation occurs at Ser47, with a minor phosphorylation at Ser51. The two phosphopeptides from GAP45 contain either one threonine and one serine or four serines, respectively, which were both phosphorylated only in one position. It is unlikely that the threonine residue in GAP45 peptide 81-96 is phosphorylated because the phosphorylated protein did not react with phospho-threonine specific antibodies (data not shown), and therefore the phosphorylated residue is Ser89. The presence of multiple serines in peptides 97-112 and 141-155 of GAP45 and poor fragmentation of the peptides in the mass spectrometer have not allowed a definitive identification of the specific residues that are modified. This information will require further studies with peptides or modified recombinant proteins.
###end p 57
###begin p 58
###xml 68 76 68 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 127 134 127 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 906 913 906 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1311 1319 1311 1319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1324 1331 1324 1331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1573 1581 1573 1581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1583 1585 1583 1585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref41">41</xref>
Although we showed that both MTIP and GAP45 could be phosphorylated in vitro, it was important to show that this also occurred in vivo. The phosphorylation of both proteins in the parasite was confirmed by two-dimensional gel analysis of the proteins with or without phosphatase treatment. In both cases multiple forms of the protein in the absence of phosphatase treatment were replaced by a single spot, consistent with the removal of phosphate residues by the enzyme. At least one of the forms of each of the proteins in the parasite prior to phosphatase treatment migrated in the same location as the enzyme-treated proteins, suggesting that the phosphorylation is only partial and substoichiometric in schizonts. We have also demonstrated that phosphorylation of GAP45 increases as parasite development progresses and that this mirrors CDPK1 expression. To confirm the phosphorylation of the proteins in vivo, we wished to purify them from parasite extracts and subject them to protease digestion and analysis by mass spectrometry of phosphorylated peptides. We were unable to purify sufficient MTIP for analysis, but sufficient GAP45 was obtained to carry out some analyses. One of the two phosphopeptides observed in recombinant GAP45 was identified, confirming that this sequence is phosphorylated both in vitro and in vivo and implicating CDPK1 as the kinase responsible. In addition, a second novel phosphorylated peptide was identified, suggesting that GAP45 is also the substrate for a second kinase. A recent study has shown that GAP45 is a substrate of PfPKB in vitro (41); it is possible that PfPKB is responsible for the phosphorylation of GAP45 at the "non-CDPK1" site identified here.
###end p 58
###begin p 59
###xml 47 53 47 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9</xref>
A diagram summarizing our findings is shown in Fig. 9. Activation of plasma membrane-situated CDPK1 by a calcium signal results in phosphorylation of GAP45 and MTIP associated with the IMC. These two membranes must be sufficiently close for this phosphorylation to occur. Our data also suggest that a calcium signal of sufficient magnitude to activate CDPK1 exists in merozoites prior to erythrocyte attachment and invasion.
###end p 59
###begin p 60
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref32">32</xref>
###xml 410 411 410 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn6">5</xref>
###xml 618 619 618 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn6">5</xref>
It is of interest to note that the phosphorylated residues in MTIP are in the N-terminal region that was not present in the recently described structure (32). The N-terminal 70 residues extend beyond the region of MTIP that is similar to calmodulin and other myosin light chains and binds the C-terminal tail of myosin A. Furthermore, phosphorylation of MTIP does not affect its binding to a MyoA tail peptide.5 The role of this N-terminal region of MTIP is not known, but it is possible that it may be important for binding to GAP45 because GAP45 is in the motor complex but does not bind directly to the myosin tail.5 Thus it is possible that phosphorylation of either or both MTIP and GAP45 may modulate the interaction between them.
###end p 60
###begin p 61
###xml 316 318 316 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 429 431 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref33">33</xref>
###xml 557 559 557 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref34">34</xref>
###xml 629 631 629 631 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 791 793 791 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref35">35</xref>
Another possibility is that phosphorylation of MTIP, which is a myosin light chain, is important in control of the motor. Phosphorylation of the regulatory light chains of myosin (RLCs) has been shown to be important in modulating the myosin motor in several systems. In skeletal muscle, phosphorylation of RLC by Ca2+/calmodulin-dependent skeletal muscle myosin light chain kinase leads to enhanced skeletal muscle contraction (33). In cardiac muscle, phosphorylation of RLC results in increased cross-bridge formation and enhanced force from contraction (34). In smooth muscle, phosphorylation of the RLC of myosin II by the Ca2+/calmodulin-dependent myosin light-chain kinase and dephosphorylation by a type 1 phosphatase are the principal mechanisms of regulation of smooth muscle tone (35). Given this evidence, it is possible that phosphorylation of MTIP and/or GAP45 will have consequences on the force generated by MyoA.
###end p 61
###begin p 62
Apart from the potential role of GAP45 phosphorylation in an interaction with MTIP or in motor control as suggested above, are there further possibilities? GAP45 has only been detected in Apicomplexan parasites, and apart from the N-terminal acylation sites and a 50-amino acid C-terminal domain, the protein is poorly conserved and of low complexity composition. It is possible that phosphorylation confers structure by adding additional negative charge to this low complexity region or facilitates interaction with other molecules important in motor function, such as GAP50 or others that have yet to be identified.
###end p 62
###begin p 63
###xml 43 51 43 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 63 65 63 65 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 73 74 73 74 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 100 113 100 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum</italic>
###xml 214 216 214 216 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 225 226 225 226 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 958 964 958 964 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 966 968 966 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref36">36</xref>
###xml 1308 1316 1308 1316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1899 1901 1899 1901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref37">37</xref>
###xml 2012 2014 2012 2014 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref38">38</xref>
###xml 2015 2017 2015 2017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref40">40</xref>
###xml 2169 2179 2169 2179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium</italic>
###xml 100 113 <span type="species:ncbi:5833">P. falciparum</span>
We have shown that K252a can inhibit CDPK1 in vitro, with an IC50 of 45 nm. Treatment of late stage P. falciparum cultures with K252a also inhibited invasion of erythrocytes by merozoites, but with a much higher IC50 of 348 nm. At high concentrations of K252a the egress of merozoites from schizonts was inhibited, whereas at intermediate concentrations egress was not affected, but merozoites failed to invade erythrocytes at the same rate as solvent-treated control parasites. The two distinct effects of K252a on parasite development could be due to non-specific inhibition of parasite kinases at high concentrations of inhibitor and a more specific inhibition of CDPK1 at intermediate concentrations. However, we cannot exclude that there are other CDPK1 substrates that play a crucial role in merozoite egress from schizonts or that GAP45 and MTIP are important in this process, as well as their role in invasion. While this paper was under review Kato et al. (36) published an article in which ontology-based pattern identification was used to establish potential targets of CDPK1. In this analysis proteins of the motor complex, including MTIP and GAP45, were identified as possible substrates. The authors identified a 2,4,6-trisubstituted purine compound, purfalcamine, that inhibits CDPK1 activity in vitro and inhibits merozoite egress from schizonts in culture. It is interesting that, like treatment with high concentrations of K252a in our study, treatment of parasites with purfalcamine also results in an inhibition of merozoite egress from the schizont. Previous investigations have demonstrated that parasite kinase activity is important for invasion of erythrocytes by merozoites. Treatment of parasites with the broad spectrum kinase inhibitor staurosporine resulted in merozoites arrested on the surface of erythrocytes, after the formation of a junction between the two cells (37). In addition, the importance of calcium in invasion and parasite motility has been shown in several studies (38-40). Phosphorylation of motor complex components by a calcium-dependent kinase may therefore be a crucial regulator of motility and host cell invasion by Plasmodium.
###end p 63
###begin p 64
###xml 110 112 110 112 <sub xmlns:xlink="http://www.w3.org/1999/xlink">22</sub>
We thank Dr. Madhusudan Kadekoppala (National Institute for Medical Research) for the gift of recombinant MSP722. Thanks also to Solabami Ogun for technical assistance with antibody generation.
###end p 64
###begin p 65
###xml 181 184 <span type="species:ncbi:11263?0.47540983606557374|species:ncbi:12167?0.09016393442622951">PVM</span>
The abbreviations used are: CDPK, calcium-dependent protein kinase; IMC, inner membrane complex; MTIP, myosin A tail domain interacting protein; GAP, glideosome-associated protein; PVM, parasitophorous vacuole membrane; MSP, merozoite surface protein; RKIP, Raf kinase inhibitor protein; MyoA, myosin A; BisTris, bis(2-hydroxyethyl)iminotris(hydroxymethyl)methane HCl; PBS, phosphate-buffered saline; CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid; SAP, shrimp alkaline phosphatase; MALDI-TOF, matrix-assisted laser desorption ionization time-of-flight; PM, plasma membrane; RLC, regulatory light chain of myosin.
###end p 65
###begin p 66
R. Tewari, personal communication.
###end p 66
###begin p 67
J. L. Green and S. R. Martin, unpublished observation.
###end p 67

